<SEC-DOCUMENT>0001641172-25-021911.txt : 20250801
<SEC-HEADER>0001641172-25-021911.hdr.sgml : 20250801
<ACCEPTANCE-DATETIME>20250801163101
ACCESSION NUMBER:		0001641172-25-021911
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250730
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250801
DATE AS OF CHANGE:		20250801

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYADIC INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001213809
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				450486747
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32513
		FILM NUMBER:		251176635

	BUSINESS ADDRESS:	
		STREET 1:		1044 NORTH U.S. HIGHWAY ONE
		STREET 2:		SUITE 201
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477
		BUSINESS PHONE:		561-743-8333

	MAIL ADDRESS:	
		STREET 1:		1044 NORTH U.S. HIGHWAY ONE
		STREET 2:		SUITE 201
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCP WORLDWIDE INC
		DATE OF NAME CHANGE:	20030110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:DYAI="http://dyadic.com/20250730">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_DYAI_dyadic.com_20250730 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250730_20250730 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001213809 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000004" name="dei:EntityCentralIndexKey">0001213809</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="dyai-20250730.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-07-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001213809</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-30</xbrli:startDate>
        <xbrli:endDate>2025-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">UNITED
STATES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 50%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">FORM
<span id="xdx_90F_edei--DocumentType_c20250730__20250730_z4lz6wWdlwK5"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 50%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (date of earliest event reported): <span style="text-decoration: underline"><span id="xdx_90E_edei--DocumentPeriodEndDate_c20250730__20250730_z0Ne0K1noqg4"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">July 30, 2025</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 50%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><img src="form8-k_001.jpg" alt=""/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><span id="xdx_90B_edei--EntityRegistrantName_c20250730__20250730_zLgbiMZdQ3pc"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000011" name="dei:EntityRegistrantName">Dyadic
International, Inc.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 50%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20250730__20250730_zvUEQIfiFVo8"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityFileNumber_c20250730__20250730_zXSf1srnmX3h"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000013" name="dei:EntityFileNumber">001-32513</ix:nonNumeric></span></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20250730__20250730_zolQmeJUfVOc"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000014" name="dei:EntityTaxIdentificationNumber">45-0486747</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityAddressAddressLine1_c20250730__20250730_znu8tfHtSXcl"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000015" name="dei:EntityAddressAddressLine1">1044
North U.S. Highway One</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20250730__20250730_zSG5AVdmZcHd"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 201</ix:nonNumeric></span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityAddressCityOrTown_c20250730__20250730_zAwRjvl3Lhhc"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000017" name="dei:EntityAddressCityOrTown">Jupiter</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20250730__20250730_zSigMkb5eWJ9"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000018" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20250730__20250730_zZ7wVXpTmjC6"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000019" name="dei:EntityAddressPostalZipCode">33477</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices and zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--CityAreaCode_c20250730__20250730_zjFhfMSvhs1i"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000020" name="dei:CityAreaCode">(561)</ix:nonNumeric></span>
<span id="xdx_90C_edei--LocalPhoneNumber_c20250730__20250730_zCez6EKfkmGl"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000021" name="dei:LocalPhoneNumber">743-8333</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
Name or Former Address, if Changed Since Last Report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--WrittenCommunications_c20250730__20250730_zQha8Cej8y38"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--SolicitingMaterial_c20250730__20250730_zqfBssKgUyY4"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--PreCommencementTenderOffer_c20250730__20250730_zQdTRPdA9rp1"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20250730__20250730_zbnIud1VwQq5"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20250730__20250730_zhwOZnKrFca7"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20250730__20250730_zHwDauJynXO4"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000027" name="dei:TradingSymbol">DYAI</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_902_edei--SecurityExchangeName_c20250730__20250730_zqrjDTk09jRa"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20250730__20250730_zb4FlHAKNcAd"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 444.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>On
July 30, 2025, Dyadic International, Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting
Agreement&#8221;) with Craig-Hallum Capital Group LLC, in its capacity as underwriter (the &#8220;Underwriter&#8221;), relating to the
issuance and sale (the &#8220;Offering&#8221;) of 6,052,000 shares of the Company&#8217;s common stock, par value $0.001 per share (&#8220;Common
Stock&#8221;). The public offering price in the Offering is $0.95 per share of Common Stock. The net proceeds to the Company from the
Offering are expected to be approximately $5.3 million, after deducting underwriting discounts and commissions and estimated offering
expenses payable by the Company. The Company intends to use the net proceeds of the Offering for working capital and general corporate
purposes, such as product development, sales and marketing. The closing of the Offering occurred on August 1, 2025.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Offering was made pursuant to the Company&#8217;s effective shelf registration statement on Form S-3 (File No. 333-273829), which was
declared effective by the Securities and Exchange Commission (the &#8220;SEC&#8221;) on August 25, 2023, and a prospectus supplement
and accompanying prospectus dated July 30, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company and the Underwriter, including for liabilities under the Securities Act of 1933, as amended,
other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting
Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to the Underwriting
Agreement, and may be subject to limitations agreed upon by the contracting parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
foregoing description of the Underwriting Agreement is not complete and is qualified in its entirety by reference to the full text of
the Underwriting Agreement, a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K (the &#8220;Current Report&#8221;)
and is incorporated by reference herein. A copy of the opinion of White &amp; Case LLP relating to the legality of the issuance and sale
of the shares of Common Stock is attached as Exhibit 5.1 to this Current Report.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Current Report on Form 8-K, including the exhibits attached hereto, does not constitute an offer to sell or the solicitation of an offer
to buy any Company securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation
or sale would be unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the press release announcing the public offering and a copy of the press release announcing the pricing of the public offering
are attached to this Current Report as Exhibits 99.1 and 99.2, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex1-1.htm">Underwriting Agreement, dated July 30, 2025, by and between Dyadic International, Inc. and Craig-Hallum Capital Group LLC, in its capacity as underwriter</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Opinion of White &amp; Case LLP</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of White &amp; Case LLP (included in Exhibit 5.1)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release issued by Dyadic International, Inc., dated July 30, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-2.htm">Press release issued by Dyadic International, Inc., dated July 31, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DYADIC
    INTERNATIONAL, INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    August 1, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
                                            Ping W. Rawson</i></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ping
    W. Rawson</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chief
    Financial Officer</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LXOd+MPudOgQp8gQ8ba4TIpbM9L690i+pXVDDIGQnPPlCDEQGa10jQynRZHDAZu2Vg6hwAoZzRm9I11vEvCzwIu2jpVx3foDU/IMemYSSuXvnfOuLZYJRLNhJIfxGKRMRlOYb0Xw1VMylS7ROK1qUKaEPVPLGp3iV//hoJ5kqHl1SUdkq8kkIMOol98QRzKGHd3Vg/hqIc9TEQy6CkTGdGu9a/l0aL4kLGtsfJzt6X8HH8KySk0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DYADIC
INTERNATIONAL, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,052,000
Shares of Common Stock, par value $0.001 per share</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
30, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRAIG-HALLUM
CAPITAL GROUP LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">222
South Ninth Street, Suite 350</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis,
Minnesota 55402</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dyadic
International, Inc., d/b/a Dyadic Applied BioSolutions, a Delaware corporation (the &ldquo;Company&rdquo;), proposes to issue and sell
to Craig-Hallum Capital Group LLC, in its capacity as underwriter (the &ldquo;Underwriter&rdquo;), an aggregate of 6,052,000 shares (the
&ldquo;Shares&rdquo;) of common stock, par value $0.001 per share (&ldquo;Common Stock&rdquo;), of the Company. The shares of Common
Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the &ldquo;Stock.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby confirms its agreement with the Underwriter concerning the purchase and sale of the Shares, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Registration Statement</U>. The Company has prepared and filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &ldquo;Securities
Act&rdquo;), a registration statement on Form S-3 (File No. 333-273829), including a prospectus, relating to the Shares. Such registration
statement, as amended at the time it became effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C
under the Securities Act to be part of the registration statement at the time of its effectiveness (&ldquo;Rule 430 Information&rdquo;),
is referred to herein as the &ldquo;Registration Statement&rdquo;; and as used herein, the term &ldquo;Preliminary Prospectus&rdquo;
means each prospectus included in such registration statement (and any amendments thereto) before effectiveness, any prospectus filed
with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at the
time of its effectiveness that omits Rule 430 Information, and the term &ldquo;Prospectus&rdquo; means the prospectus in the form first
used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of
sales of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule 462(b) under the Securities Act
(the &ldquo;Rule 462 Registration Statement&rdquo;), then any reference herein to the term &ldquo;Registration Statement&rdquo; shall
be deemed to include such Rule 462 Registration Statement. Any reference in this underwriting agreement (this &ldquo;Agreement&rdquo;)
to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated
by reference therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the effective date of the Registration Statement
or the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &ldquo;amend,&rdquo; &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed
to refer to and include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and
regulations of the Commission thereunder (collectively, the &ldquo;Exchange Act&rdquo;) that are deemed to be incorporated by reference
therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and
the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
or prior to the Applicable Time (as defined below), the Company had prepared the following information (collectively with the pricing
information set forth on Annex A, the &ldquo;Pricing Disclosure Package&rdquo;): a Preliminary Prospectus dated July 30, 2025 and each
&ldquo;free-writing prospectus&rdquo; (as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Applicable
Time&rdquo; means 6:00 P.M., New York City time, on July 30, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Purchase of the Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company agrees to issue and sell the Shares to the Underwriter as provided in this Agreement, and the Underwriter, on the basis of
the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees to purchase at
a price per Share of $0.8835 (the &ldquo;Purchase Price&rdquo;) from the Company the number of Shares set forth opposite the Underwriter&rsquo;s
name in Schedule 1 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company understands that the Underwriter intends to make a public offering of the Shares, and initially to offer the Shares on the
terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriter may offer and sell Shares
to or through any affiliate of the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Payment for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the Underwriter
at the offices of Faegre Drinker Biddle &amp; Reath LLP, counsel for the Underwriter, at 200 Wells Fargo Center 90 S. Seventh Street,
Minneapolis, Minnesota 55402 at 10:00 A.M. New York City time on August 1, 2025, or at such other time or place on the same or such other
date, not later than the fifth business day thereafter, as the Underwriter and the Company may agree upon in writing. The time and date
of such payment for the Shares is referred to herein as the &ldquo;Closing Date.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
for the Shares to be purchased on the Closing Date shall be made against delivery to the Underwriter of the Shares to be purchased on
the Closing Date, with any transfer taxes payable in connection with the sale of such Shares duly paid by the Company. Delivery of the
Shares shall be made in book-entry form registered in such names and in such denominations as the Underwriter shall request in writing
not later than two full business days prior to such date, through the facilities of The Depository Trust Company (&ldquo;DTC&rdquo;)
unless the Underwriter shall otherwise instruct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company acknowledges and agrees that the Underwriter is acting solely in the capacity of an arm&rsquo;s length contractual counterparty
to the Company with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the
offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally, the Underwriter
is not advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction.
The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation
and appraisal of the transactions contemplated hereby, and the Underwriter shall not have any responsibility or liability to the Company
with respect thereto. Any review by the Underwriter of the Company, the transactions contemplated hereby or other matters relating to
such transactions will be performed solely for the benefit of the Underwriter and shall not be on behalf of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Representations and Warranties of the Company</U>. The Company represents and warrants to the Underwriter that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Compliance with Registration Requirements</I>. The Registration Statement has become effective under the Securities Act. The Company
has complied with all requests of the Commission for additional or supplemental information, if any. No stop order suspending the effectiveness
of the Registration Statement is in effect and no proceedings for such purpose or pursuant to Section 8A of the Securities Act against
the Company or related to the offering of the Shares have been instituted or are pending or, to the best knowledge of the Company, are
contemplated or threatened by the Commission. At the time the Company&rsquo;s Annual Report on Form 10-K for the year ended December
31, 2024 (the &ldquo;Annual Report&rdquo;) was filed with the Commission, or, if later, at the time the Registration Statement was originally
filed with the Commission, the Company met the then-applicable requirements for use of Form S-3 under the Securities Act. The Company
is eligible to use Form S-3 under the Securities Act and meets the transaction requirements with respect to the aggregate market value
of securities being sold pursuant to this offering and during the 12 months prior to this offering, as set forth in General Instruction
I.B.6 of Form S-3. The Company meets the requirements for use of Form S-3 under the Securities Act specified in FINRA Conduct Rule 5110(h)(1)(C).
The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the Pricing Disclosure Package and
the Prospectus, at the time they were filed, complied in all material respects with the requirements of the Exchange Act, and none of
such documents contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Disclosure</I>. Each Preliminary Prospectus and the Prospectus when filed complied in all material respects with the Securities Act
and, if filed by electronic transmission pursuant to the Commission&rsquo;s Electronic Data Gathering Analysis and Retrieval system (&ldquo;EDGAR&rdquo;),
was identical (except as may be permitted by Regulation S-T under the Securities Act) to the copy thereof delivered to the Underwriter
for use in connection with the offer and sale of the Shares. Each of the Registration Statement and any post-effective amendment thereto,
at the time it became or becomes effective, complied and will comply in all material respects with the Securities Act and did not and
will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein not misleading. As of the Applicable Time, the Pricing Disclosure Package (including any preliminary prospectus
wrapper) did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Prospectus
(including any Prospectus wrapper), as of its date, did not, and at the Closing Date will not, contain any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The representations and warranties set forth in the three immediately preceding sentences do not apply
to statements in or omissions from the Registration Statement or any post-effective amendment thereto, or the Prospectus or the Pricing
Disclosure Package, or any amendments or supplements thereto, made in reliance upon and in conformity with written information relating
to any Underwriter furnished to the Company in writing by the Underwriter expressly for use therein, it being understood and agreed that
the only such information consists of the information described in Section 7(b) below. There are no contracts or other documents required
to be described in the Pricing Disclosure Package or the Prospectus or to be filed as an exhibit to the Registration Statement which
have not been described or filed as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Free Writing Prospectuses; Road Show</I>. As of the determination date referenced in Rule 164(h) under the Securities Act, the Company
was not, is not or will not be (as applicable) an &ldquo;ineligible issuer&rdquo; in connection with the offering of the Shares pursuant
to Rules 164, 405 and 433 under the Securities Act. Each free writing prospectus that the Company is required to file pursuant to Rule
433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities
Act. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act
or that was prepared by or on behalf of or used or referred to by the Company complies or will comply in all material respects with the
requirements of Rule 433 under the Securities Act, including timely filing with the Commission or retention where required and legending,
and each such free writing prospectus, as of its issue date and at all subsequent times through the completion of the public offer and
sale of the Shares did not, does not and will not include any information that conflicted, conflicts or will conflict with the information
contained in the Registration Statement, the Prospectus or any preliminary prospectus and not superseded or modified. Each free writing
prospectus, when considered together with the Pricing Disclosure Package, did not, as of the Applicable Time, contain any untrue statement
of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading. Except for the free writing prospectuses, if any, identified in Annex A hereto, electronic road
shows, if any, furnished to the Underwriter before first use, and any document not constituting a prospectus pursuant to Section 2(a)(10)(a)
of the Securities Act or Rule 134 under the Securities Act (an &ldquo;Issuer Free Writing Prospectus&rdquo;), the Company has not prepared,
used or referred to, and will not, without the Underwriter&rsquo;s prior written consent, which consent shall not be unreasonably withheld,
prepare, use or refer to, any free writing prospectus. Each road show, when considered together with the Pricing Disclosure Package,
did not, as of the Applicable Time, contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements therein, in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<I>Distribution of Offering Material by the Company</I>. Prior to the completion of the Underwriter&rsquo;s distribution of the Shares,
the Company has not distributed and will not distribute any offering material in connection with the offering and sale of the Shares
other than the Registration Statement, the Pricing Disclosure Package, the Prospectus or any free writing prospectus reviewed and consented
to by the Underwriter, which consent shall not be unreasonably withheld, the free writing prospectuses, if any, identified on Annex A
hereto and any oral or written communication with potential investors undertaken in reliance on either Section 5(d) of, or Rule 163B
under, the Securities Act (each, a &ldquo;Testing-the-Waters Communication&rdquo; and, if a written communication, a &ldquo;Written Testing-the-Waters
Communication&rdquo;). The Company has not distributed or approved for distribution any Written Testing-the-Waters Communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<I>The Underwriting Agreement</I>. This Agreement has been duly authorized, executed and delivered by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<I>Authorization of the Shares</I>. (i) The Shares have been duly authorized for issuance and sale pursuant to this Agreement and, when
issued and delivered by the Company against payment therefor pursuant to this Agreement, will be validly issued, fully paid and nonassessable;
and (ii) and the issuance and sale of the Shares is not subject to any preemptive rights, rights of first refusal or other similar rights
to subscribe for or purchase the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<I>No Applicable Registration or Other Similar Rights</I>. There are no persons with registration or other similar rights to have any
equity or debt securities registered for sale under the Registration Statement or included in the offering contemplated by this Agreement,
except for such rights as have been duly waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<I>No Material Adverse Change</I>. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, subsequent to the respective dates as of which information is given in the Registration Statement, the Pricing Disclosure
Package and the Prospectus: (i) there has been no material adverse change, or any development that would reasonably be expected to result
in a material adverse change, in the condition, financial or otherwise, or in the earnings, business, properties, operations, assets,
liabilities or prospects, whether or not arising from transactions in the ordinary course of business, of the Company and its subsidiaries,
considered as one entity (any such change being referred to herein as a &ldquo;Material Adverse Change&rdquo;); (ii) the Company and
its subsidiaries, considered as one entity, have not incurred any material liability or obligation, indirect, direct or contingent, including
without limitation any losses or interference with its business from fire, explosion, flood, earthquakes, accident or other calamity,
whether or not covered by insurance, or from any strike, labor dispute or court or governmental action, order or decree, that are material,
individually or in the aggregate, to the Company and its subsidiaries, considered as one entity, or has entered into any transactions
not in the ordinary course of business; and (iii) there has not been any material decrease in the capital stock or any material increase
in any short-term or long-term indebtedness of the Company or its subsidiaries and there has been no dividend or distribution of any
kind declared, paid or made by the Company or, except for dividends paid to the Company or other subsidiaries, by any of the Company&rsquo;s
subsidiaries on any class of capital stock, or any repurchase or redemption by the Company or any of its subsidiaries of any class of
capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<I>Independent Accountants</I>. To the Company&rsquo;s knowledge, Crowe LLP, which has expressed its opinion with respect to the financial
statements (which term as used in this Agreement includes the related notes thereto) filed with the Commission as a part of the Registration
Statement, the Pricing Disclosure Package and the Prospectus, is (i) an independent registered public accounting firm as required by
the Securities Act, the Exchange Act, and the rules of the Public Company Accounting Oversight Board (&ldquo;PCAOB&rdquo;), (ii) in compliance
with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X under the Securities
Act and (iii) a registered public accounting firm as defined by the PCAOB whose registration has not been suspended or revoked and who
has not requested such registration to be withdrawn.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<I>Financial Statements</I>. The financial statements filed with the Commission as a part of the Registration Statement, the Pricing
Disclosure Package and the Prospectus present fairly, in all material respects, the consolidated financial position of the Company and
its subsidiaries as of the dates indicated and the results of their operations, changes in stockholders&rsquo; equity and cash flows
for the periods specified. Such financial statements have been prepared in conformity with generally accepted accounting principles as
applied in the United States (&ldquo;GAAP&rdquo;), applied on a consistent basis throughout the periods involved, except as may be expressly
stated in the related notes thereto. All disclosures contained in the Registration Statement, any preliminary prospectus or the Prospectus
and any free writing prospectus, that constitute non-GAAP financial measures (as defined by the rules and regulations under the Securities
Act and the Exchange Act) comply with Regulation G under the Exchange Act and Item 10 of Regulation S-K under the Securities Act, as
applicable. To the Company&rsquo;s knowledge, no person who has been suspended or barred from being associated with a registered public
accounting firm, or who has failed to comply with any sanction pursuant to Rule 5300 promulgated by the PCAOB, has participated in or
otherwise aided the preparation of, or audited, the financial statements, supporting schedules or other financial data filed with the
Commission as a part of the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<I>Company&rsquo;s Accounting System</I>. The Company and each of its subsidiaries make and keep accurate books and records and maintain
a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorization; (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance
with management&rsquo;s general or specific authorization; (iv) the recorded accountability for assets is compared with existing assets
at reasonable intervals and appropriate action is taken with respect to any differences; and (v) the interactive data in eXtensible Business
Reporting Language included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus
fairly presents the information called for in all material respects and is prepared in accordance with the Commission&rsquo;s rules and
guidelines applicable thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<I>Disclosure Controls and Procedures; Deficiencies in or Changes to Internal Control Over Financial Reporting</I>. Except as described
in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has established and maintains disclosure
controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Exchange Act), which (i) are designed to ensure that material
information relating to the Company, including its consolidated subsidiaries, is made known to the Company&rsquo;s principal executive
officer and its principal financial officer by others within those entities, particularly during the periods in which the periodic reports
required under the Exchange Act are being prepared; (ii) have been evaluated by management of the Company for effectiveness as of the
end of the Company&rsquo;s most recent fiscal quarter; and (iii) are effective in all material respects to perform the functions for
which they were established. Since the end of the Company&rsquo;s most recent audited fiscal year, there have been no significant deficiencies
or material weakness in the Company&rsquo;s internal control over financial reporting (whether or not remediated) and no change in the
Company&rsquo;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect,
the Company&rsquo;s internal control over financial reporting. The Company is not aware of any change in its internal control over financial
reporting that has occurred during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially
affect, the Company&rsquo;s internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<I>Incorporation and Good Standing of the Company</I>. The Company has been duly incorporated and is validly existing as a corporation
in good standing under the laws of the State of Delaware and has the corporate power and authority to own, lease and operate its properties
and to conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and to enter
into and perform its obligations under this Agreement. The Company is duly qualified as a foreign corporation to transact business and
is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property
or the conduct of business, except where the failure to be so qualified or in good standing, as the case may be, or to have such power
or authority would not, individually or in the aggregate, have a Material Adverse Effect (defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<I>Subsidiaries</I>. Each of the Company&rsquo;s &ldquo;subsidiaries&rdquo; (for purposes of this Agreement, as defined in Rule 405 under
the Securities Act) has been duly incorporated or organized, as the case may be, and is validly existing and in good standing (where
such concept is recognized) under the laws of the jurisdiction of its incorporation or organization and has the power and authority (corporate
or other) to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus. Each of the Company&rsquo;s subsidiaries is duly qualified to transact business and is in good
standing (where such concept is recognized) in each jurisdiction in which such qualification is required, whether by reason of the ownership
or leasing of property or the conduct of business, except where the failure to be so qualified or in good standing, as the case may be,
or have such power or authority would not, individually or in the aggregate, have a Material Adverse Effect. All of the issued and outstanding
capital stock or other equity or ownership interests of each of the Company&rsquo;s subsidiaries have been duly authorized and validly
issued, are fully paid and nonassessable and are owned by the Company, directly or through subsidiaries, free and clear of any security
interest, mortgage, pledge, lien, encumbrance or adverse claim. The Company does not own or control, directly or indirectly, any corporation,
association or other entity other than the subsidiaries listed in Exhibit 21.1 to the Annual Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<I>Capitalization and Other Capital Stock Matters</I>. The authorized, issued and outstanding capital stock of the Company is as set
forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus (other than for subsequent issuances, if any,
pursuant to employee benefit plans, or upon the exercise of outstanding options or warrants, in each case described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus). The Shares, when issued pursuant to the terms of this Agreement will conform,
in all material respects, to the description thereof contained in the Pricing Disclosure Package. All of the issued and outstanding shares
of Common Stock have been duly authorized and validly issued, are fully paid and nonassessable and have been issued in compliance with
all applicable federal and state securities laws. None of the outstanding shares of Common Stock was issued in violation of any preemptive
rights, rights of first refusal or other similar rights to subscribe for or purchase securities of the Company. There are no authorized
or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities
convertible into or exchangeable or exercisable for, any capital stock of the Company or any of its subsidiaries other than those described
in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The descriptions of the Company&rsquo;s stock option,
stock bonus and other stock plans or arrangements (each, a &ldquo;Company Stock Plan&rdquo;), and the options or other rights granted
thereunder, set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus accurately and fairly presents,
in all material respects, the information required to be shown with respect to such plans, arrangements, options and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<I>Stock Exchange Listing</I>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on
the Nasdaq Stock Market (&ldquo;Nasdaq&rdquo;), and except as disclosed in the Prospectus, the Company (i) has taken no action designed
to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common
Stock from Nasdaq and (ii) has not received any notification that the Commission or Nasdaq is contemplating terminating such registration
or listing. Except as disclosed in the Prospectus, to the Company&rsquo;s knowledge, it is in compliance with all applicable listing
requirements of Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<I>Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required</I>. Neither the Company nor any of its
subsidiaries is in violation of its charter or by-laws, partnership agreement or operating agreement or similar organizational documents,
as applicable, or is in default (or, with the giving of notice or lapse of time, would be in default) (&ldquo;Default&rdquo;) under any
indenture, loan, credit agreement, note, lease, license agreement, contract, franchise or other instrument (including, without limitation,
any pledge agreement, security agreement, mortgage or other instrument or agreement evidencing, guaranteeing, securing or relating to
indebtedness) to which the Company or any of its subsidiaries is a party or by which it or any of them may be bound, or to which any
of their respective properties or assets are subject (each, an &ldquo;Existing Instrument&rdquo;), except for such Defaults as could
not be expected, individually or in the aggregate, to have a material adverse effect on the condition (financial or other), earnings,
business, properties, operations, assets, liabilities or prospects of the Company and its subsidiaries, considered as one entity (a &ldquo;Material
Adverse Effect&rdquo;). The Company&rsquo;s execution, delivery and performance of this Agreement, consummation of the transactions contemplated
hereby and by the Registration Statement, the Pricing Disclosure Package and the Prospectus and the issuance and sale of the Shares (i)
have been duly authorized by all necessary corporate action and will not result in any violation of the provisions of the charter or
by-laws, partnership agreement or operating agreement or similar organizational documents, as applicable, of the Company or any subsidiary
(ii) will not conflict with or constitute a breach of, or Default or a Debt Repayment Triggering Event (as defined below) under, or result
in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries
pursuant to, or require the consent of any other party to, any Existing Instrument, except as could not be expected, individually or
in the aggregate, to have a Material Adverse Effect and (iii) will not result in any violation of any law, administrative regulation
or administrative or court decree applicable to the Company or any of its subsidiaries, except for such violations as would not be expected,
individually or in the aggregate, to have a Material Adverse Effect. No consent, approval, authorization or other order of, or registration
or filing with, any court or other governmental or regulatory authority or agency, is required for the Company&rsquo;s execution, delivery
and performance of this Agreement and the consummation of the transactions contemplated hereby and by the Registration Statement, the
Pricing Disclosure Package and the Prospectus, except such as have been obtained or made or will be made by the Company under the Securities
Act and such as may be required under applicable state securities or blue sky laws or FINRA. As used herein, a &ldquo;Debt Repayment
Triggering Event&rdquo; means any event or condition which gives, or with the giving of notice or lapse of time would give, the holder
of any note, debenture or other evidence of indebtedness (or any person acting on such holder&rsquo;s behalf) the right to require the
repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<I>Compliance with Laws.</I> The Company and its subsidiaries have been and are in compliance with all applicable laws, rules and regulations,
except where failure to be so in compliance could not be expected, individually or in the aggregate, to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<I>No Material Actions or Proceedings</I>. There is no action, suit, proceeding, inquiry or investigation brought by or before any governmental
entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries, which
if determined adversely to the Company or any of its subsidiaries would reasonably be expected, individually or in the aggregate, to
have a Material Adverse Effect or materially and adversely affect the consummation of the transactions contemplated by this Agreement
or the performance by the Company of its obligations hereunder; and the aggregate of all pending legal or governmental proceedings to
which the Company or any such subsidiary is a party or of which any of their respective properties or assets is the subject, including
ordinary routine litigation incidental to the business, if determined adversely to the Company, would not reasonably be expected, individually
or in the aggregate, to have a Material Adverse Effect. No material labor dispute with the employees of the Company or any of its subsidiaries
exists or, to the knowledge of the Company, is threatened or imminent. To the knowledge of the Company, no material labor dispute with
the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists, or is threatened or imminent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<I>Intellectual Property</I>. (i) The Company and its subsidiaries own or have the right to use all patents, patent rights, statutory
invention rights, community designs, invention disclosures, rights in utility models and industrial designs, inventions, registered and
unregistered copyrights (including copyrights in software), intellectual property rights in technology and software, data, knowhow (including
trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service
marks, business names, trade names, logos, slogans, trade dress, design rights, Internet domain names, social media accounts, any other
designations of source or origin, and any applications (including provisional applications), registrations, or renewals for any of the
foregoing, rights to publicity and privacy and/or other intellectual property (collectively, &ldquo;Intellectual Property&rdquo;) used
in or necessary for the conduct of their respective businesses; (ii) the Company&rsquo;s and its subsidiaries&rsquo; believe that its
products, services and conduct of their respective businesses do not infringe, misappropriate or otherwise violate, and has not infringed,
misappropriated or otherwise violated, any Intellectual Property of any person; (iii) the Company and its subsidiaries have not received
any written notice of, or are otherwise aware of, any claim relating to Intellectual Property, including any claim alleging any infringement,
misappropriation or other violation of, or conflict regarding, any Intellectual Property of a third party, and the Company and its subsidiaries
are unaware of any fact which would form a reasonable basis for any such claim; and (iv) to the knowledge of the Company, the Intellectual
Property of the Company and its subsidiaries is not being and has not been infringed, misappropriated or otherwise violated by any person
and there is no pending or threatened action, suit, proceeding or claim by the Company or any of its subsidiaries against a third party
regarding the foregoing. All Intellectual Property owned by the Company (such Intellectual Property, the &ldquo;Company Intellectual
Property&rdquo;) is valid, subsisting and enforceable and there is no pending or, to the Company&rsquo;s knowledge, threatened action,
suit, proceeding or claim by any third party challenging the validity, ownership, registrability, scope or enforceability of any Company
Intellectual Property and the Company and its subsidiaries are unaware of any facts or circumstances which would form a reasonable basis
for any such claim. The Company&rsquo;s Intellectual Property has been duly maintained and is in full force and effect, and all actions
or fees necessary to prosecute or maintain the Company Intellectual Property have been timely taken, met or paid and the Company believes
that there are no material defects in any of the Company Intellectual Property. Each person who is or was an employee or contractor of
the Company or any of its subsidiaries and who is, was or, in the case of current employees and contractors, is reasonably expected to
be involved in the creation or development of any Intellectual Property for or on behalf of the Company has executed a valid, written
agreement containing an effective, present and valid assignment to the Company or any of its subsidiaries of such person&rsquo;s rights
in and to such Intellectual Property. The Company is not aware of any violation by any current or former employee of the Company or any
of its subsidiaries of any term of any agreement or covenant to or with a former employer of such employee where the basis of such violation
relates to such employee&rsquo;s employment with the Company or any of its subsidiaries or actions undertaken by the employee while employed
with the Company or any of its subsidiaries. The Company has taken all reasonable steps for a company of its size necessary to maintain
the confidentiality of the trade secrets and other confidential Intellectual Property used in connection with the business of the Company
and its subsidiaries, and the confidentiality of such trade secrets and confidential Intellectual Property has not been compromised in
such a matter as would deprive the Company&rsquo;s trade secrets from the protections afforded to trade secrets under the applicable
law, or which would preclude the Company from enforcing confidentiality obligations against persons who have agreed, or otherwise have
a duty to, maintain the confidentiality of such material confidential Intellectual Property. With respect to licenses to third parties
of Company Intellectual Property, to the knowledge of the Company, no such third party is in material breach of the applicable licenses
and contractual obligations related thereto. No Intellectual Property has been obtained or is being used by the Company or its subsidiaries
in violation of any material contractual obligations binding on the Company or its subsidiaries in violation of any contractual rights
of any person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<I>All Necessary Permits, etc</I>. The Company and its subsidiaries possess such valid and current certificates, authorizations or permits
required by state, federal or foreign regulatory agencies or bodies to conduct their respective businesses as currently conducted and
as described in the Registration Statement, the Pricing Disclosure Package or the Prospectus (&ldquo;Permits&rdquo;), except where the
failure to possess the same or so qualify would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect. Neither the Company nor any of its subsidiaries is in violation of, or in default under, any of the Permits or has received any
notice of proceedings relating to the revocation or modification of, or non-compliance with the Permits, except for such violations,
defaults or proceedings if resolved unfavorably, would not reasonably be expected, individually or in the aggregate, to result in a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<I>Title to Properties</I>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the
Company and its subsidiaries have good and marketable title to all of the real and personal property and other assets reflected as owned
in the financial statements referred to in Section 1(j) above (or elsewhere in the Registration Statement, the Pricing Disclosure Package
or the Prospectus), in each case free and clear of any security interests, mortgages, liens, encumbrances, equities, adverse claims and
other defects, except such as do not materially and adversely affect the value of such property and do not materially interfere with
the use made or proposed to be made of such property by the Company. The real property, improvements, equipment and personal property
held under lease by the Company or any of its subsidiaries are held under valid and enforceable leases, with such exceptions as are not
material and do not materially interfere with the use made or proposed to be made of such real property, improvements, equipment or personal
property by the Company or such subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<I>Tax Law Compliance</I>. Except in any case in which failure to pay or file (as applicable) would not, individually or in the aggregate,
have a Material Adverse Effect, the Company and its subsidiaries have filed all necessary federal, state and foreign income and franchise
tax returns or have properly requested extensions thereof and have paid all taxes required to be paid by any of them and, if due and
payable, any related or similar assessment, fine or penalty levied against any of them except as may be being contested in good faith
and by appropriate proceedings. Except to the extent of any inadequacy that would not, individually or in the aggregate, result in a
Material Adverse Effect, the Company has made adequate charges, accruals and reserves in the applicable financial statements referred
to in Section 1(j) above in respect of all federal, state and foreign income and franchise taxes for all periods as to which the tax
liability of the Company or any of its subsidiaries has not been finally determined.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<I>Insurance</I>. Each of the Company and its subsidiaries are insured by recognized, financially sound and reputable institutions with
policies in such amounts and with such deductibles and covering such risks as are reasonably deemed adequate and customary for their
businesses including, but not limited to, policies covering real and personal property owned or leased by the Company and its subsidiaries
against theft, damage, destruction, acts of vandalism and earthquakes and policies covering the Company and its subsidiaries for product
liability claims and clinical trial liability claims. The Company has no reason to believe that it or any of its subsidiaries will not
be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar
institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has been denied
any insurance coverage which it has sought or for which it has applied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<I>Compliance with Environmental Laws</I>. Except as would not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect: (i) neither the Company nor any of its subsidiaries is in violation of any federal, state, local or foreign statute,
law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including
any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment
(including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without
limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic
substances, hazardous substances, petroleum or petroleum products (collectively, &ldquo;Hazardous Materials&rdquo;) or to the manufacture,
processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, &ldquo;Environmental
Laws&rdquo;); (ii) the Company and its subsidiaries have all permits, authorizations and approvals required under any applicable Environmental
Laws and are each in compliance with their requirements; (iii) there are no pending or, to the knowledge of the Company, threatened administrative,
regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or
proceedings relating to any Environmental Law against the Company or any of its subsidiaries; and (iv) there are no events or circumstances
that might reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or proceeding by any
private party or governmental body or agency, against or affecting the Company or any of its subsidiaries relating to Hazardous Materials
or any Environmental Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<I>No Rated Debt or Preferred Securities.</I> There are no debt or preferred securities issued, or guaranteed, by the Company or its
subsidiaries that are rated by a &ldquo;nationally recognized statistical rating organization,&rdquo; as such term is defined in Section
3(a)(62) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<I>ERISA Compliance</I>. The Company and its subsidiaries and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee
Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &ldquo;ERISA&rdquo;))
established or maintained by the Company, its subsidiaries or their &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance
in all material respects with ERISA. &ldquo;ERISA Affiliate&rdquo; means, with respect to the Company or any of its subsidiaries, any
member of any group of organizations described in Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended,
and the regulations and published interpretations thereunder (the &ldquo;Code&rdquo;) of which the Company or such subsidiary is a member.
No &ldquo;reportable event&rdquo; (as defined under ERISA), for which notice has not been waived, has occurred or is reasonably expected
to occur with respect to any &ldquo;employee benefit plan&rdquo; established or maintained by the Company, its subsidiaries or any of
their ERISA Affiliates. No &ldquo;employee benefit plan&rdquo; established or maintained by the Company, its subsidiaries or any of their
ERISA Affiliates, if such &ldquo;employee benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded benefit liabilities&rdquo;
(as defined under ERISA). Neither the Company, its subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects
to incur any liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &ldquo;employee benefit plan&rdquo;
or (ii) Sections 412, 4971, 4975 or 4980B of the Code. Each employee benefit plan established or maintained by the Company, its subsidiaries
or any of their ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and, to the knowledge
of the Company, nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
 <I>Company Not an &ldquo;Investment Company.&rdquo;</I> The Company is not, and will not be, either after receipt of payment for
the Shares, or after the application of the proceeds therefrom as described under &ldquo;Use of Proceeds&rdquo; in the Registration Statement,
the Pricing Disclosure Package or the Prospectus, required to register as an &ldquo;investment company&rdquo; under the Investment Company
Act of 1940, as amended (the &ldquo;Investment Company Act&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
 <I>No Price Stabilization or Manipulation; Compliance with Regulation M</I>. Neither the Company nor any of its subsidiaries has
taken, directly or indirectly, without giving effect to activities by the Underwriter, any action designed to or that might reasonably
be expected to cause or result in stabilization or manipulation of the price of the Shares or of any &ldquo;reference security&rdquo;
(as defined in Rule 100 of Regulation M under the Exchange Act (&ldquo;Regulation M&rdquo;)) with respect to the Shares, whether to facilitate
the sale or resale of the Shares or otherwise, and has taken no action which would directly or indirectly violate Regulation M.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
 <I>Related-Party Transactions</I>. There are no business relationships or related-party transactions involving the Company or any
of its subsidiaries or any other person required to be described in the Registration Statement, the Pricing Disclosure Package or the
Prospectus that have not been described as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
 <I>Parties to Lock-Up Agreements</I>. The Company has furnished to the Underwriter a letter agreement in the form attached hereto
as Annex B (the &ldquo;Lock-up Agreement&rdquo;) from each executive officer and director of the Company and each beneficial owner of
10% or more of the Company&rsquo;s outstanding common stock as of the date hereof (each, a 10% Holder&rdquo;). If any additional persons
shall become directors or officers of the Company prior to the end of the 90-day restricted period referred to in Section 4(h) hereof,
the Company shall cause each such person, prior to or contemporaneously with their appointment or election as a director or officer of
the Company, to execute and deliver to the Underwriter a Lock-up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
 <I>Statistical and Market-Related Data</I>. All statistical, demographic and market-related data included in the Registration Statement,
the Pricing Disclosure Package or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry,
to be reliable and accurate. To the extent required, the Company has obtained the written consent to the use of such data from such sources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
 <I>No Unlawful Contributions or Other Payments</I>. Neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any employee or agent of the Company or any of its subsidiaries, has made any contribution or other payment to any official
of, or candidate for, any federal, state or foreign office in violation of any applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
 <I>Unlawful Payments</I>. Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer,
agent, employee, controlled affiliate or other person acting on behalf of the Company or any of its subsidiaries has, in the course of
its actions for, or on behalf of, the Company or any of its subsidiaries (i) used any corporate funds for any unlawful contribution,
gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any
domestic government official, &ldquo;foreign official&rdquo; (as defined in the U.S. Foreign Corrupt Practices Act of 1977, as amended,
and the rules and regulations thereunder, collectively, the &ldquo;FCPA&rdquo;) or employee from corporate funds; (iii) violated or is
in violation of any provision of the FCPA or any applicable non-U.S. anti-bribery statute or regulation; or (iv) made any unlawful bribe,
rebate, payoff, influence payment, kickback or other unlawful payment to any domestic government official, such foreign official or employee;
and the Company and its subsidiaries and, to the knowledge of the Company, the Company&rsquo;s other controlled affiliates have conducted
their respective businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure,
and which are reasonably expected to continue to ensure, continued compliance therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<I>Money Laundering Laws</I>. The operations of the Company and its subsidiaries are, and have been conducted at all times, in compliance
with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar
applicable rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &ldquo;Money
Laundering Laws&rdquo;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the
Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
 <I>OFAC</I>. Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, after due inquiry, any director,
officer, agent, employee, controlled affiliate or person acting on behalf of the Company or any of its subsidiaries is currently subject
to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;OFAC&rdquo;)
or the U.S. Department of State and including, without limitation, the designation as a &ldquo;specially designated national&rdquo; or
&ldquo;blocked person&rdquo;, the United Nations Security Council, the European Union, His Majesty&rsquo;s Treasury or other relevant
sanctions authority (&ldquo;Sanctions&rdquo;), nor is the Company located, organized or resident in a country or territory that is the
subject or target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Syria, the Crimea Region and the non-government
controlled areas of the Zaporizhzhia and Kherson Regions of Ukraine, the so-called Donetsk People&rsquo;s Republic, the so-called Luhansk
People&rsquo;s Republic and any other Covered Region of Ukraine identified pursuant to Executive Order 14065 (each, a &ldquo;Sanctioned
Country&rdquo;); and the Company will not directly or indirectly use the proceeds of this offering, or lend, contribute or otherwise
make available such proceeds to any subsidiary, or any joint venture partner or other person or entity, (i) for the purpose of financing
the activities of or business with any person, or in any country or territory, that currently is the subject of Sanctions, (ii) to fund
or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by
any person (including any person participating in the transaction whether as underwriter, advisor, investor or otherwise) of applicable
Sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
 <I>Brokers</I>. Except pursuant to this Agreement, there is no broker, finder or other party that is entitled to receive from the
Company any brokerage or finder&rsquo;s fee or other fee or commission as a result of any transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
 <I>Forward-Looking Statements.</I> Each financial or operational projection or other &ldquo;forward-looking statement&rdquo; (as
defined by Section 27A of the Securities Act or Section 21E of the Exchange Act) contained in the Registration Statement, the Pricing
Disclosure Package or the Prospectus was so included by the Company in good faith and with reasonable basis after due consideration by
the Company of the underlying assumptions, estimates and other applicable facts and circumstances. No such statement was made with the
knowledge of any executive officer or director of the Company that is was false or misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
 [Intentionally omitted.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<I>Compliance with Data Privacy Laws</I>. To the Company&rsquo;s knowledge, the Company and its subsidiaries are, and at all prior times
were, in material compliance with all applicable data privacy and security laws and regulations (collectively, the &ldquo;Privacy Laws&rdquo;).
To ensure compliance with the Privacy Laws, the Company and its subsidiaries have in place, comply with, and take commercially reasonable
steps reasonably designed to ensure compliance in all material respects with their policies and procedures relating to data privacy and
security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (as defined below) (the &ldquo;Policies&rdquo;).
The Company and its subsidiaries have at all times made all disclosures to users or customers required by the Privacy Laws, and none
of such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or in violation of any Privacy
Laws in any material respect. The Company further certifies that neither it nor any subsidiary: (i) has received written notice of any
actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws, (ii) is currently conducting
or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii)
is a party to any order, decree, or agreement from or with a governmental or regulatory authority or agency that imposes any obligation
or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<I>Cybersecurity</I>. To the Company&rsquo;s knowledge, the Company and its subsidiaries&rsquo; information technology assets and equipment,
computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &ldquo;IT Systems&rdquo;) are
adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Company
and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware
and other corruptants. The Company and its subsidiaries have implemented and maintained commercially reasonable physical, technical and
administrative controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the
integrity, continuous operation, redundancy and security of all IT Systems and data, including &ldquo;Personal Data,&rdquo; used in connection
with their businesses. &ldquo;Personal Data&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, e-mail
address, photograph, social security number or tax identification number, driver&rsquo;s license number, passport number, credit card
number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally identifying information&rdquo;
under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR; (iv) any information which
would qualify as &ldquo;protected health information&rdquo; under HIPAA; and (v) any other piece of information that allows the identification
of such natural person, or his or her family, or permits the collection or analysis of any data related to an identified person&rsquo;s
health or sexual orientation. There have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for
those that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal
review or investigations relating to the same. The Company and its subsidiaries are presently in material compliance with all applicable
laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection
of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
 <I>No Rights to Purchase Preferred Stock.</I> The issuance and sale of the Shares as contemplated hereby will not cause any holder
of any shares of capital stock, securities convertible into or exchangeable or exercisable for capital stock or options, warrants or
other rights to purchase capital stock or any other securities of the Company to have any right to acquire any shares of preferred stock
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
 <I>Dividend Restrictions</I>. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, no subsidiary of the Company is prohibited or restricted, directly or indirectly, from paying dividends to the Company, or
from making any other distribution with respect to such subsidiary&rsquo;s equity securities or from repaying to the Company or any other
subsidiary of the Company any amounts that may from time to time become due under any loans or advances to such subsidiary from the Company
or from transferring any property or assets to the Company or to any other subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
 <I>Sarbanes-Oxley.</I> The Company is, and after giving effect to the offering and sale of Shares will be, in compliance in all material
respects with all applicable effective provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations of the Commission promulgated
thereunder.</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
 <I>Margin Rules</I>. Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company
as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or
X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
 <I>Status under the Securities Act</I>. At the time of filing the Registration Statement and any post-effective amendment thereto,
at the earliest time thereafter that the Company or any offering participant made a bona fide offer (within the meaning of Rule 164(h)(2)
under the Securities Act) of the Shares and at the date hereof, the Company was not and is not or will not be (as applicable) an &ldquo;ineligible
issuer,&rdquo; in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Further Agreements of the Company</U>. The Company covenants and agrees with the Underwriter that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Required Filings.</I> The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b)
and Rule 430A, 430B or 430C under the Securities Act, and will file any Issuer Free Writing Prospectus to the extent required by Rule
433 under the Securities Act; and the Company will file promptly all reports and any definitive proxy or information statements required
to be filed by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date
of the Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Shares;
and the Company will furnish PDF copies of the Prospectus and each Issuer Free Writing Prospectus (if any and to the extent not previously
delivered) to the Underwriter in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date
of this Agreement as the Underwriter may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Delivery of Copies.</I> The Company will deliver, without charge, to the Underwriter, copies of the Prospectus (including all amendments
and supplements thereto and documents incorporated by reference therein and each Issuer Free Writing Prospectus) as the Underwriter may
reasonably request during the Prospectus Delivery Period in PDF format. As used herein, the term &ldquo;Prospectus Delivery Period&rdquo;
means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriter
a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities
Act) in connection with sales of the Shares by any Underwriter or dealer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Amendments or Supplements, Issuer Free Writing Prospectuses.</I> In connection with the transactions contemplated by this Agreement,
before making, preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing
any amendment or supplement to the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company will furnish
to the Underwriter and counsel for the Underwriter a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for
review and will not make, prepare, use, authorize, approve, refer to or file any such, Issuer Free Writing Prospectus or file any such
proposed amendment or supplement to which the Underwriter reasonably object.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<I>Notice to the Underwriter.</I> The Company will advise the Underwriter promptly, and confirm such advice in writing (which confirmation
may be delivered by electronic mail), (i) when any amendment to the Registration Statement has been filed or becomes effective; (ii)
when any supplement to the Pricing Disclosure Package, the Prospectus, any Issuer Free Writing Prospectus or any amendment to the Prospectus
has been filed or distributed; (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment
or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other
request by the Commission for any additional information; (iv) of the issuance by the Commission or any other governmental or regulatory
authority of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary
Prospectus, any of the Pricing Disclosure Package, or the Prospectus or the initiation or, to the Company&rsquo;s knowledge, threatening
of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; (v) of the occurrence of any event or development
within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure Package, or any Issuer Free
Writing Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure
Package, or any such Issuer Free Writing Prospectus is delivered to a purchaser, not misleading; and (v) of the receipt by the Company
of any notice with respect to any suspension of the qualification of the Shares for offer and sale in any jurisdiction or the initiation
or, to the Company&rsquo;s knowledge, threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts
to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use
of any Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or suspending any such qualification of the Shares
and, if any such order is issued, will use its reasonable best efforts to obtain as soon as possible the withdrawal thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<I>Ongoing Compliance.</I> (1) If during the Prospectus Delivery Period (i) any event or development shall occur or condition shall exist
as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus
is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply with applicable law,
the Company will promptly notify the Underwriter thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission
and furnish to the Underwriter and to such dealers as the Underwriter may designate such amendments or supplements to the Prospectus
(or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in
the Prospectus as so amended or supplemented (or any document to be filed with the Commission and incorporated by reference therein)
will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus
will comply with applicable law and (2) if at any time prior to the Closing Date (i) any event or development shall occur or condition
shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances
existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement
the Pricing Disclosure Package to comply with applicable law, the Company will promptly notify the Underwriter thereof and forthwith
prepare and, subject to paragraph (c) above, file with the Commission (to the extent required) and furnish to the Underwriter and to
such dealers as the Underwriter may designate such amendments or supplements to the Pricing Disclosure Package (or any document to be
filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Pricing Disclosure
Package as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure Package is delivered
to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<I>Blue Sky Compliance.</I> The Company will qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions
as the Underwriter shall reasonably request and will continue such qualifications in effect so long as required for distribution of the
Shares; <U>provided</U> that the Company shall not be required to (i) qualify as a foreign corporation or other entity or as a dealer
in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to service
of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<I>Earning Statement. </I>The Company will make generally available to its security holders and the Underwriter as soon as practicable
an earning statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated
thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &ldquo;effective
date&rdquo; (as defined in Rule 158) of the Registration Statement; <U>provided</U> that the Company will be deemed to have furnished
such statements to its security holders and the Underwriter to the extent they are filed on EDGAR or any successor system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <I>Clear
Market.</I> For a period of 90 days after the date of the Prospectus, the Company will not (i)&#8239;offer, pledge, sell, contract to
sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase,
hedge, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission a registration statement
under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or exchangeable for Stock,
or publicly disclose the intention to undertake any of the foregoing, or (ii)&#8239;enter into any hedging, swap or other agreement that
transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any such other securities, whether any
such transaction described in clause (i)&#8239;or (ii)&#8239;above is to be settled by delivery of Stock or such other securities, in
cash or otherwise, without the prior written consent of the Underwriter, other than the Shares to be sold hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
restrictions described above do not apply to (i)&#8239;the issuance of shares of Stock or securities convertible into or exercisable
for shares of Stock pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options
(including net exercise) or the settlement of RSUs (including net settlement), in each case outstanding on the date of this Agreement
and described in the Prospectus; (ii)&#8239;grants of stock options, stock awards, restricted stock, RSUs, or other equity awards and
the issuance of shares of Stock or securities convertible into or exercisable or exchangeable for shares of Stock (whether upon the exercise
of stock options or otherwise) to the Company&rsquo;s employees, officers, directors, advisors, or consultants pursuant to the terms
of an inducement plan or an equity compensation plan in effect as of the Closing Date and described in the Prospectus; (iii)&#8239;the
issuance of up to 10% of the outstanding shares of Stock, or securities convertible into, exercisable for, or which are otherwise exchangeable
for, Stock, immediately following the Closing Date, in acquisitions, strategic transactions of assets or acquisition of equity of another
entity or&#8239;in connection with a transaction with an unaffiliated third party that includes a bona fide commercial relationship (including
joint ventures, marketing or distribution arrangements, collaboration agreements, intellectual property license agreements, or lending
agreements or arrangements), <U>provided</U> that such recipients enter into a lock-up agreement with the Underwriter; or (iv)&#8239;the
filing of any registration statement on Form&#8239;S-8 relating to securities granted or to be granted pursuant to any plan in effect
on the date of this Agreement and described in the Prospectus or any assumed benefit plan pursuant to an acquisition or similar strategic
transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <I>Use
of Proceeds.</I> The Company will apply the net proceeds from the sale of the Shares as described in each of the Registration Statement,
the Pricing Disclosure Package and the Prospectus under the heading &ldquo;Use of Proceeds.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <I>No
Stabilization.</I> Neither the Company nor its subsidiaries will take, and the Company will ensure that its controlled affiliates will
not take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization
or manipulation of the price of the Stock and will not take any action prohibited by Regulation M under the Exchange Act in connection
with the distribution of the Shares contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <I>Exchange
Listing.</I> The Company will use its reasonable best efforts to list, subject to notice of issuance, the Shares on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <I>Reports.</I>
For a period of two years from the date of this Agreement, so long as the Shares are outstanding, the Company will furnish to the Underwriter,
as soon as commercially reasonable after the date on which they are available, copies of all reports or other communications (financial
or other) furnished to holders of Stock, and copies of any reports and financial statements furnished to or filed with the Commission
or any national securities exchange or automatic quotation system; <U>provided</U> the Company will be deemed to have furnished such
reports and financial statements to the Underwriter to the extent they are filed on EDGAR or any successor system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <I>Record
Retention.</I> The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing
Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>Certain
Agreements of the Underwriter</U>. The Underwriter hereby represents and agrees that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) It
has not and will not use, authorize use of, refer to or participate in the planning for use of, any &ldquo;free writing prospectus,&rdquo;
as defined in Rule&#8239;405 under the Securities Act (which term includes use of any written information furnished to the Commission
by the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other than
(i)&#8239;a free writing prospectus that contains no &ldquo;issuer information&rdquo; (as defined in Rule&#8239;433(h)(2)&#8239;under
the Securities Act) that was not included (including through incorporation by reference) in the Preliminary Prospectus or a previously
filed Issuer Free Writing Prospectus, (ii)&#8239;any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section&#8239;3(c)&#8239;or
Section&#8239;4(c)&#8239;above (including any electronic road show approved in advance by the Company), or (iii)&#8239;any free writing
prospectus prepared by the Underwriter and approved by the Company in advance in writing (each such free writing prospectus referred
to in clauses (i)&#8239;or (iii), an &ldquo;Underwriter Free Writing Prospectus&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) It
has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final terms
of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) It
is not subject to any pending proceeding under Section&#8239;8A of the Securities Act with respect to the offering (and will promptly
notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>Conditions
of Underwriter&rsquo;s Obligations.</U> The obligation of the Underwriter to purchase the Shares on the Closing Date as provided herein
is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <I>Registration
Compliance; No Stop Order.</I> No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding
for such purpose, or pursuant to Section&#8239;8A under the Securities Act shall be pending before or threatened by the Commission; the
Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act (in the
case of an Issuer Free Writing Prospectus, to the extent required by Rule&#8239;433 under the Securities Act) and in accordance with
Section&#8239;4(a)&#8239;hereof; and all requests by the Commission for additional information shall have been complied with to the reasonable
satisfaction of the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <I>Representations
and Warranties.</I> The representations and warranties of the Company contained herein shall be true and correct on the date hereof and
on and as of the Closing Date; and the statements of the Company and its officers made in any certificates delivered pursuant to this
Agreement shall be true and correct on and as of the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <I>No
Material Adverse Change.</I> No event or condition of a type described in Section&#8239;3(h)&#8239;hereof shall have occurred or shall
exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and
the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the Underwriter makes it impracticable
or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date on the terms and in the manner contemplated
by this Agreement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <I>Officer&rsquo;s
Certificate.</I> The Underwriter shall have received on and as of the Closing Date a certificate of the chief financial officer or chief
accounting officer of the Company and one additional senior executive officer of the Company who is satisfactory to the Underwriter (i)&#8239;confirming
that such officers have carefully reviewed the Registration Statement, the Pricing Disclosure Package and the Prospectus and, to the
knowledge of such officers, the representations set forth in Sections 3(a)&#8239;and 3(b)&#8239;hereof are true and correct, (ii)&#8239;confirming
that the other representations and warranties of the Company in this Agreement are true and correct and that the Company has complied
with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date,
and (iii)&#8239;to the effect set forth in paragraphs (a), (b)&#8239;and (c)&#8239;above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <I>Comfort
Letters.</I> On the date of this Agreement and on the Closing Date, Crowe LLP shall have furnished to the Underwriter, at the request
of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriter, in form and substance reasonably
satisfactory to the Underwriter, containing statements and information of the type customarily included in accountants&rsquo; &ldquo;comfort
letters&rdquo; to underwriters with respect to the financial statements and certain financial information contained or incorporated by
reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus; <U>provided</U> that the letter delivered
on the Closing Date shall use a &ldquo;cut-off&rdquo; date no more than three business days prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <I>Opinion
and 10b-5 Statement of Counsel for the Company.</I> White &amp; Case LLP, counsel for the Company, shall have furnished to the Underwriter,
at the request of the Company, its written opinion and 10b-5 statement, dated the Closing Date and addressed to the Underwriter, in form
and substance reasonably satisfactory to the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <I>Opinion
of Intellectual Property Counsel for the Company. </I>Webb &amp; Co., intellectual property counsel for the Company, shall have furnished
to the Underwriter, at the request of the Company, its written opinion and 10b-5 statement, dated the Closing Date and addressed to the
Underwriter, in form and substance reasonably satisfactory to the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
 <I>Opinion of Counsel for the Underwriter.</I> The
Underwriter shall have received on and as of the Closing Date an opinion that shall contain a negative assurance statement, addressed
to the Underwriter, of Faegre Drinker Biddle &amp; Reath LLP, counsel for the Underwriter, with respect to such matters as the Underwriter
may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable
them to pass upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<I>No Legal Impediment to Issuance and Sale.</I> No action shall have been taken and no statute, rule, regulation or order shall have
been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date,
prevent the issuance or sale of the Shares by the Company; and no injunction or order of any federal, state or foreign court shall have
been issued that would, as of the Closing Date, prevent the issuance or sale of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <I>Good
Standing</I>. The Underwriter shall have received on and as of the Closing Date satisfactory evidence of the good standing of the Company
and its subsidiaries in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Underwriter
may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities
of such jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <I>Lock-up
Agreements</I>. The &ldquo;lock-up&rdquo; agreements, each substantially in the form of Annex B hereto, between you and certain officers,
directors and 10% Holders of the Company relating to sales and certain other dispositions of shares of Stock or certain other securities,
delivered to you on or before the date hereof, shall be in full force and effect on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <FONT STYLE="background-color: white"><I>CFO
Certificate</I>. On the date of this Agreement and on the Closing Date, the Company shall have furnished to the Underwriter a certificate,
dated the respective dates of delivery thereof and addressed to the Underwriter, of its chief financial officer with respect to certain
financial data contained in the Pricing Disclosure Package and the Prospectus, providing &ldquo;management comfort&rdquo; with respect
to such information, in form and substance reasonably satisfactory to the Underwriter.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <I>&#8239;&#8239;Exchange
Listing</I>. The Company shall have submitted a Supplemental Listing Application&#8239;to Nasdaq with respect to the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <I>&#8239;Additional
Documents</I>. On or prior to the Closing Date, the Company shall have furnished to the Underwriter such further certificates and documents
as the Underwriter may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with
the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>&#8239;Indemnification and Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <I>Indemnification
of the Underwriter.</I> The Company agrees to indemnify and hold harmless the Underwriter, its affiliates, directors and officers and
each person, if any, who controls the Underwriter within the meaning of Section&#8239;15 of the Securities Act or Section&#8239;20 of
the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, reasonable and
documented legal fees and other expenses reasonably incurred in connection with any suit, action or proceeding or any claim asserted,
as such fees and expenses are incurred) that arise out of, or are based upon, (i)&#8239;any untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material
fact required to be stated therein or necessary in order to make the statements therein, not misleading, or (ii)&#8239;any untrue statement
or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary
Prospectus, any Issuer Free Writing Prospectus, any &ldquo;issuer information&rdquo; filed or required to be filed pursuant to Rule&#8239;433(d)&#8239;under
the Securities Act, any road show as defined in Rule&#8239;433(h)&#8239;under the Securities Act (a &ldquo;road show&rdquo;) or any Pricing
Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), or caused by any omission or alleged
omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which
they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based
upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information
relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use therein, it being understood and
agreed that the only such information furnished by the Underwriter consists of the information described as such in paragraph (b)&#8239;below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <I>Indemnification
of the Company.</I> The Underwriter agrees to indemnify and hold harmless the Company, its directors, its officers who signed the Registration
Statement and each person, if any, who controls the Company within the meaning of Section&#8239;15 of the Securities Act or Section&#8239;20
of the Exchange Act to the same extent as the indemnity set forth in paragraph (a)&#8239;above, but only with respect to any losses,
claims, damages or liabilities (including, without limitation, reasonable and documented legal fees and other expenses incurred in connection
with any suit, action, or proceeding or any claim asserted, as such fees and expenses are incurred) that arise out of, or are based upon,
any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information
relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use in the Registration Statement, the
Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any road show or
any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), it being understood and
agreed upon that the only such information furnished by the Underwriter consists of the following information in the Prospectus furnished
on behalf of the Underwriter: (i) the concession figure appearing in the second sentence of the second paragraph under the caption &ldquo;Underwriting,&rdquo;
(ii) paragraphs one, two and three under the caption &ldquo;Underwriting&mdash;Price Stabilization, Short Positions and Penalty Bids,&rdquo;
(iii) the second, third and fourth sentence in the first paragraph under the caption &ldquo;Underwriting&mdash;Electronic Offer, Sale
and Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <I>Notice
and Procedures.</I> If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be
brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this
Section&#8239;7, such person (the &ldquo;Indemnified Person&rdquo;) shall promptly notify the person against whom such indemnification
may be sought (the &ldquo;Indemnifying Person&rdquo;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person
shall not relieve it from any liability that it may have under the preceding paragraphs of this Section&#8239;7 except to the extent
that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided further</U>,
that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person
otherwise than under the preceding paragraphs of this Section&#8239;7. If any such proceeding shall be brought or asserted against an
Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying
Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section&#8239;that the Indemnifying
Person may designate in such proceeding and shall pay the reasonably incurred and documented fees and expenses in such proceeding and
shall pay the reasonably incurred and documented fees and expenses of such counsel related to such proceeding, as incurred. In any such
proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be
at the expense of such Indemnified Person unless (i)&#8239;the Indemnifying Person and the Indemnified Person shall have mutually agreed
to the contrary; (ii)&#8239;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to
the Indemnified Person; (iii)&#8239;the Indemnified Person shall have reasonably concluded that there may be legal defenses available
to it that are different from or in addition to those available to the Indemnifying Person; or (iv)&#8239;the named parties in any such
proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both
parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and
agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable
for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all
such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates,
directors and officers and any control persons of the Underwriter shall be designated in writing by the Underwriter and any such separate
firm for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company shall
be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without
its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees
to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. Notwithstanding
the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified
Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement
of any proceeding effected without its written consent if (i)&#8239;such settlement is entered into more than 30 days after receipt by
the Indemnifying Person of such request and (ii)&#8239;the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance
with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified
Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been
a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x)&#8239;includes an
unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all
liability on claims that are the subject matter of such proceeding and (y)&#8239;does not include any statement as to or any admission
of fault, culpability or a failure to act by or on behalf of any Indemnified Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <I>Contribution.</I>
If the indemnification provided for in paragraphs (a)&#8239;or (b)&#8239;above is unavailable to an Indemnified Person or insufficient
in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in
lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as
a result of such losses, claims, damages or liabilities (i)&#8239;in such proportion as is appropriate to reflect the relative benefits
received by the Company, on the one hand, and the Underwriter on the other, from the offering of the Shares or (ii)&#8239;if the allocation
provided by clause (i)&#8239;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i)&#8239;but also the relative fault of the Company, on the one hand, and the Underwriter on the other,
in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant
equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriter on the other, shall be
deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale
of the Shares and the total underwriting discounts and commissions received by the Underwriter in connection therewith, in each case
as set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of the Shares. The relative fault of the
Company, on the one hand, and the Underwriter on the other, shall be determined by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied
by the Company or by the Underwriter and the parties&rsquo; relative intent, knowledge, access to information and opportunity to correct
or prevent such statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <I>Limitation
on Liability.</I> The Company and the Underwriter agree that it would not be just and equitable if contribution pursuant to paragraph
(d)&#8239;above were determined by <U>pro rata</U> allocation or by any other method of allocation that does not take account of the
equitable considerations referred to in paragraph (d)&#8239;above. The amount paid or payable by an Indemnified Person as a result of
the losses, claims, damages and liabilities referred to in paragraph (d)&#8239;above shall be deemed to include, subject to the limitations
set forth above, any documented legal or other expenses reasonably incurred by such Indemnified Person in connection with any such action
or claim. Notwithstanding the provisions of paragraphs (d)&#8239;and (e), in no event shall the Underwriter be required to contribute
any amount in excess of the amount by which the total underwriting discounts and commissions received by the Underwriter with respect
to the offering of the Shares exceeds the amount of any damages that the Underwriter has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the
meaning of Section&#8239;11(f)&#8239;of the Securities Act) shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <I>Non-Exclusive
Remedies.</I> The remedies provided for in this Section&#8239;7 paragraphs (a)&#8239;through (e)&#8239;are not exclusive and shall not
limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <U>Effectiveness
of Agreement</U>. This Agreement shall become effective as of the date first written above upon the execution and delivery hereof by
the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <U>Termination</U>.
This Agreement may be terminated in the absolute discretion of the Underwriter, by notice to the Company, if after the execution and
delivery of this Agreement and on or prior to the Closing Date (i)&#8239;trading generally shall have been suspended or materially limited
on or by any of the New York Stock Exchange or Nasdaq; (ii)&#8239;trading of any securities issued or guaranteed by the Company shall
have been suspended on any exchange or in any over-the-counter market; (iii)&#8239;a general moratorium on commercial banking activities
shall have been declared by federal or New York State authorities; or (iv)&#8239;there shall have occurred any outbreak or escalation
of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the
judgment of the Underwriter, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or
delivery of the Shares on the Closing Date on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package
and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <U>Payment
of Expenses</U><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay
or cause to be paid the following: (i) the fees, disbursements and expenses of the Company&rsquo;s counsel and accountants in connection
with the registration of the Shares under the Act and all other expenses in connection with the preparation, printing, reproduction and
filing of the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Pricing Disclosure Package
and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (ii) the cost of printing
or producing this Agreement, the Blue Sky survey, closing documents (including any compilations thereof) and any other documents in connection
with the offering, purchase, sale and delivery of the Shares; (iii) all expenses in connection with the qualification of the Shares for
offering and sale under state securities laws; (iv) all fees and expenses in connection with listing the Shares on Nasdaq; (v) the filing
fees incident to and in connection with, any required review by FINRA of the terms of the sale of the Shares; (vi) the cost of preparing
stock certificates, if applicable; (vii) the cost and charges of any transfer agent, or registrar; (viii) the costs and expenses of the
Company relating to investor presentations on any &ldquo;road show&rdquo; undertaken in connection with the marketing of the Shares,
including without limitation, expenses associated with the production of road show slides and graphics, fees; and (ix) all other costs
and expenses incident to the performance of its obligations hereunder which are not otherwise specifically provided for in this Section
10. It is understood, however, that, except as provided in this Section 10 and Section 7 hereof, the Underwriter will pay all of its
own costs and expenses; <U>provided</U>, however, that the Company will reimburse the Underwriter for out-of-pocket expenses (including
fees and expenses of its counsel) reasonably incurred and documented by the Underwriter in connection with this Agreement and the offering
contemplated hereby in an aggregate amount that shall not exceed $75,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) If
(i)&#8239;this Agreement is terminated pursuant to Section&#8239;9, (ii)&#8239;the Company for any reason fails to tender the Shares
for delivery to the Underwriter, or (iii) the Underwriter declines to purchase the Shares for any reason permitted under this Agreement,
the Company agrees to reimburse the Underwriter for out-of-pocket costs and expenses (including the fees and expenses of its counsel)
reasonably incurred by the Underwriter in connection with this Agreement and the offering contemplated hereby in an aggregate amount
that shall not exceed $75,000. For the avoidance of doubt, it is understood that the Company shall not pay or reimburse any costs, fees
or expenses incurred by any Underwriter that defaults on its obligation to purchase the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <U>Persons
Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective
successors and the officers and directors and any controlling persons referred to herein, and the affiliates of the Underwriter referred
to in Section&#8239;7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable
right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from any Underwriter
shall be deemed to be a successor merely by reason of such purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. <U>Survival</U>.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriter contained
in this Agreement or made by or on behalf of the Company or the Underwriter pursuant to this Agreement or any certificate delivered pursuant
hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination
of this Agreement or any investigation made by or on behalf of the Company or the Underwriter or the directors, officers, controlling
persons or affiliates referred to in Section&#8239;7 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <U>Certain
Defined Terms</U>. For purposes of this Agreement, (a)&#8239;except where otherwise expressly provided, the term &ldquo;affiliate&rdquo;
has the meaning set forth in Rule&#8239;405 under the Securities Act; (b)&#8239;the term &ldquo;business day&rdquo; means any day other
than a day on which banks are permitted or required to be closed in New York City and (c)&#8239;the term &ldquo;subsidiary&rdquo; has
the meaning set forth in Rule&#8239;405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. <U>Compliance
with USA Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October&#8239;26,
2001)), the Underwriter is required to obtain, verify and record information that identifies its clients, including the Company, which
information may include the name and address of its clients, as well as other information that will allow the Underwriter to properly
identify its clients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <I>Notices.</I>
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted
and confirmed by any standard form of telecommunication. Notices to the Underwriter shall be given to the Underwriter c/o Craig-Hallum
Capital Group LLC, 222 South Ninth Street, Suite 350 Minneapolis, Minnesota 5540, Attention: Head of Investment Banking, with a copy
(which shall not constitute notice) to Faegre Drinker Biddle &amp; Reath LLP, 200 Wells Fargo Center 90 S. Seventh Street, Minneapolis,
Minnesota 55402 Attention: Jonathan Zimmerman. Notices to the Company shall be given to it at Dyadic International, Inc., 1044 North
U.S. Highway One, Suite 201, Jupiter, FL 33477, Attention: Ping Rawson, with a copy (which shall not constitute notice) to White &amp;
Case LLP, 1221 Avenue of the Americas, New York, NY 10020 Attention: Kimberly C. Petillo-D&eacute;cossard and Jessica Y. Chen.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <I>Governing
Law.</I> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed
in accordance with the laws of the State of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <I>Submission
to Jurisdiction</I>. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough
of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby. The Company agrees that all claims in respect of any such suit, action or proceeding may be heard and determined by any such
court. The Company waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such
courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding
upon the Company and may be enforced in any court to the jurisdiction of which Company is subject by a suit upon such judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <I>Waiver
of Jury Trial.</I> Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating
to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <I>Recognition
of the U.S. Special Resolution Regimes</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#8239; In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from the Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation,
were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#8239; In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of the Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against the Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Section&#8239;15(e):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;BHC
Act Affiliate&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12
U.S.C. &sect; 1841(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Covered
Entity&rdquo; means any of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#8239;a
&ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#8239;a
&ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#8239;a
&ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Default
Right&rdquo; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2
or 382.1, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;U.S.
Special Resolution Regime&rdquo; means each of (i)&#8239;the Federal Deposit Insurance Act and the regulations promulgated thereunder
and (ii)&#8239;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <I>Counterparts.</I>
This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each
of which shall be an original and all of which together shall constitute one and the same instrument. This Agreement may be delivered
via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com
or www.echosign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <I>Amendments
or Waivers.</I> No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall
in any event be effective unless the same shall be in writing and signed by the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <I>Headings.</I>
The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation
of, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing is in accordance with your understanding, please indicate your acceptance of this Agreement by signing in the space provided
below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DYADIC
    INTERNATIONAL, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Mark Emalfarb</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    Emalfarb</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted:
    As of the date first written above</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CRAIG-HALLUM
    CAPITAL GROUP llc</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Rick Hartfiel</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rick
    Hartfiel</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head
    of Investment Banking</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Underwriting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">Underwriter</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Number of Shares</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: left; padding-bottom: 1pt">Craig-Hallum Capital Group, LLC</TD><TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: right">6,052,000</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right; padding-bottom: 1pt">Total:</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,052,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer
Free Writing Prospectus</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
Information Provided Orally by the Underwriter</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Share: $0.95</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Shares: 6,052,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM&#8239;OF
LOCK-UP AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
30, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRAIG-HALLUM
CAPITAL GROUP LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">222
South Ninth Street, Suite 350</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis,
Minnesota 55402</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dyadic
    International, Inc. &mdash; Public Offering</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that you, as underwriter (the &ldquo;Underwriter&rdquo;), propose to enter into an underwriting agreement (the
&ldquo;Underwriting Agreement&rdquo;) with Dyadic International, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), providing
for the public offering (the &ldquo;Public Offering&rdquo;) by the Underwriter, of common stock, par value $0.001 per share (the &ldquo;Common
Stock&rdquo;), of the Company (the &ldquo;Securities&rdquo;). Capitalized terms used herein and not otherwise defined shall have the
meanings set forth in the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the Underwriter&rsquo;s agreement to purchase and make the Public Offering of the Securities, and for other good and
valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent
of the Underwriter, the undersigned will not, and will not cause any direct or indirect affiliate to, during the period beginning on
the date hereof and ending at the close of business 90 days after the date of the final prospectus supplement relating to the Public
Offering (such period, the &ldquo;Restricted Period&rdquo;), (1) offer, pledge, sell, contract to sell, sell any option or contract to
purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose
of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock
(including without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the undersigned
in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise
of a stock option or warrant) (collectively with the Common Stock, the &ldquo;Lock-Up Securities&rdquo;), (2) enter into any hedging,
swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the Lock-Up
Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in
cash or otherwise, (3) make any demand for or exercise any right with respect to the registration of any Lock-Up Securities, or (4) publicly
disclose the intention to do any of the foregoing. The undersigned acknowledges and agrees that the foregoing precludes the undersigned
from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or
sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument,
however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition
or transfer (whether by the undersigned or any other person) of any economic consequences of ownership, in whole or in part, directly
or indirectly, of any Lock-Up Securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be
settled by delivery of Lock-Up Securities, in cash or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, the undersigned may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
transfer or dispose of the undersigned&rsquo;s Lock-Up Securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
as a bona fide gift or gifts, including but not limited to a charity or educational institution, or for bona fide estate planning purposes,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
by will or intestacy,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
to any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned, or if the undersigned
is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes of this Letter Agreement,
&ldquo;immediate family&rdquo; shall mean any relationship by blood, current or former marriage, domestic partnership or adoption, not
more remote than first cousin),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
to a corporation, partnership, limited liability company or other entity of which the undersigned or the immediate family of the undersigned
are the legal and beneficial owner of all of the outstanding equity securities or similar interests,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv)
above,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
if the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation,
partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under
the Securities Act of 1933, as amended) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing
or managed by or under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where
the undersigned is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership),
or (B) as part of a distribution to members, partners, shareholders or other equityholders of the undersigned,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement, or related
court order,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
to the Company from an employee of the Company upon death, disability or termination of employment, in each case, of such employee,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
as part of a sale of the undersigned&rsquo;s Lock-Up Securities acquired in the Public Offering and any transaction with respect to shares
of Common Stock or other securities convertible into or exercisable or exchangeable for Common Stock acquired in open market transactions
after the completion of the Public Offering,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
to the Company in connection with the vesting, settlement, or exercise of restricted stock, restricted stock units, performance units
options, warrants or other rights to purchase shares of Common Stock (including, in each case, by way of &ldquo;net&rdquo; or &ldquo;cashless&rdquo;
exercise), including for the payment of exercise price and tax and remittance payments due as a result of the vesting, settlement, or
exercise of such restricted stock, restricted stock units, performance units, options, warrants or rights, provided that any such shares
of Common Stock received upon such exercise, vesting or settlement (other than such shares as are transferred or surrendered to the Company
in connection with such vesting, settlement or exercise event) shall be subject to the terms of this Letter Agreement, and provided further
that any such restricted stock, restricted stock units, performance units, options, warrants or rights are held by the undersigned pursuant
to an agreement or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan which is
described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved by the Board of
Directors of the Company and made to all holders of the Company&rsquo;s capital stock involving a Change of Control of the Company. For
purposes hereof, &ldquo;Change of Control&rdquo; shall mean the transfer (whether by tender offer, merger, consolidation or other similar
transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons (other than the Underwriter
pursuant to the Public Offering), of shares of capital stock if, after such transfer, such person or group of affiliated persons would
hold more than 50% of the outstanding voting securities of the Company (or the surviving entity)); provided that in the event that such
tender offer, merger, consolidation or other similar transaction is not completed, the undersigned&rsquo;s Lock-Up Securities shall remain
subject to the provisions of this Letter Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>provided</U>
that (A) in the case of any transfer or distribution pursuant to clauses (a)(i), (ii), (iii), (iv), (v) and (vi), such transfer shall
not involve a disposition for value, (B) in the case of any transfer or distribution pursuant to clauses (a)(i), (ii), (iii), (iv), (v),
(vi) and (vii), each donee, devisee, transferee or distributee shall execute and deliver to the Underwriter a lock-up letter in the form
of this Letter Agreement, (C) in the case of any transfer or distribution pursuant to clause (a)(ii), (iii), (iv), (v), and (vi), no
filing by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Exchange Act, or other public
announcement reporting a reduction in beneficial ownership of shares of Common Stock shall be required or shall be made voluntarily in
connection with such transfer or distribution (other than a filing on a Form 5 made after the expiration of the Restricted Period referred
to above) and (D) in the case of any transfer or distribution pursuant to clauses (a)(i), (vii), (viii), (ix) and (x) it shall be a condition
to such transfer that no public filing, report or announcement shall be voluntarily made and if any filing under Section 16(a) of the
Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of Common Stock
in connection with such transfer or distribution shall be legally required during the Restricted Period, such filing, report or announcement
shall clearly indicate the nature and conditions of such transfer in the footnotes thereto or by transaction code;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
exercise outstanding options or warrants, or settle restricted stock, restricted stock units, performance units or other equity awards
pursuant to plans described in the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided that any Lock-up
Securities received upon such exercise, vesting or settlement shall be subject to the terms of this Letter Agreement; <U>provided</U>
that if the undersigned is required to make any filing under Section 16(a) of the Exchange Act, or other public filing, report or announcement
during the Restricted Period, the undersigned shall clearly indicate that the filing relates to the circumstances described in this clause
by footnotes thereto or transaction code and that the shares of Common Stock received upon the exercise, vesting or settlement, as applicable,
are subject to this Letter Agreement, and no public filing, report or announcement shall be voluntarily made;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
establish trading plans pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of Lock-Up Securities (each such plan,
a &ldquo;Trading Plan&rdquo;); provided that such Trading Plans do not provide for the transfer of Lock-Up Securities during the Restricted
Period; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
sell or transfer shares pursuant to a Trading Plan in existence as of the date hereof; provided that any filing under Section 16(a) of
the Exchange Act that is made in connection with any such sales or transfers during the Restricted Period shall state that such sales
have been executed under a Trading Plan and shall also state the date such Trading Plan was adopted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the undersigned is not a natural person, the undersigned represents and warrants that no single natural person, entity or &ldquo;group&rdquo;
(within the meaning of Section 13(d)(3) of the Exchange Act) other than a natural person, entity or &ldquo;group&rdquo; (as described
above) that has executed a Letter Agreement in substantially the same form as this Letter Agreement, beneficially owns, directly or indirectly,
50% or more of the common equity interests, or 50% or more of the voting power, in the undersigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described
herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of
this Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Letter Agreement. All
authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns,
heirs or personal representatives of the undersigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned acknowledges and agrees that the Underwriter has not provided any recommendation or investment advice nor has the Underwriter
solicited any action from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted its
own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges
and agrees that, although the Underwriter may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures
to you in connection with the Public Offering, the Underwriter is not making a recommendation to you to enter into this Letter Agreement
and nothing set forth in such disclosures is intended to suggest that the Underwriter is making such a recommendation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that, (i) if the Underwriting Agreement does not become effective by August 31, 2025, (ii) if the Underwriting
Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery
of the Common Stock to be sold thereunder, (iii) the Company notifies the Underwriter, or the Underwriter notifies the Company, in writing
prior to the execution of the Underwriting Agreement that it does not intend to proceed with the Public Offering, or (iv) prior to payment
for the Securities, the Registration Statement is withdrawn prior to the execution of the Underwriting Agreement, the Letter Agreement
shall automatically terminate and be of no further force or effect and the undersigned shall be released from all obligations under this
Letter Agreement. The undersigned understands that the Underwriter is entering into the Underwriting Agreement and proceeding with the
Public Offering in reliance upon this Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby consents to receipt of this Letter Agreement in electronic form and understands and agrees that this Letter Agreement
may be signed electronically. In the event that any signature is delivered by facsimile transmission, electronic mail, or otherwise by
electronic transmission (including any electronic signature complying with the U.S. federal ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com)
evidencing an intent to sign this Letter Agreement, such facsimile transmission, electronic mail or other electronic transmission shall
create a valid and binding obligation of the undersigned with the same force and effect as if such signature were an original. Execution
and delivery of this Letter Agreement by facsimile transmission, electronic mail or other electronic transmission is legal, valid and
binding for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
page follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Letter Agreement and any claim, controversy or dispute arising under or related to this Letter Agreement shall be governed by and construed
in accordance with the laws of the State of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Security Holder <I>(Print exact name)</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    not signing in an individual capacity:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory <I>(Print)</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory <I>(Print)</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(indicate
    capacity of person signing if signing as custodian, trustee, or on behalf of an entity)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 28; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex5-1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 49%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 1, 2025</FONT></P>
                         <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                         <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dyadic
International, Inc.</FONT></FONT></P>
                         <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1044
North U.S. Highway One, Suite 201</FONT></FONT></FONT></P>
                         <P STYLE="margin-top: 0; margin-bottom: 0">Jupiter,
Florida 33477</P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
  <TD STYLE="text-align: right; width: 49%"><IMG SRC="ex5-1_002.jpg" ALT=""></TD>
  </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Dyadic International, Inc. (d/b/a Dyadic Applied BioSolutions), a corporation organized under the laws of Delaware
(the &ldquo;<U>Company</U>&rdquo;), in connection with offering by the Company of 6,052,000 shares of the Company&rsquo;s common stock,
par value $0.001 per share (the &ldquo;<U>Shares</U>&rdquo;), by the Company pursuant to a registration statement on Form S-3 (Registration
No. 333-273829) (the &ldquo;<U>Registration Statement</U>&rdquo;), filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), the prospectus included within the Registration
Statement (the &ldquo;<U>Base Prospectus</U>&rdquo;), and the prospectus supplement dated July 30, 2025 filed with the Commission pursuant
to Rule 424(b) under the Securities Act (together with the Base Prospectus, the &ldquo;<U>Prospectus</U>&rdquo;). The Shares are sold
pursuant to an underwriting agreement dated July 30, 2025, between the Company and Craig-Hallum Capital Group LLC (the &ldquo;<U>Underwriting
Agreement</U>&rdquo;) as described in the Registration Statement and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter is rendered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act, and no opinion
is expressed herein as to any matter pertaining to the contents of the Registration Statement or related prospectus, any prospectus filed
pursuant to Rule 424(b) with respect thereto, other than as expressly stated herein with respect to the issuance of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our opinions expressed below, we have examined originals or copies certified or otherwise identified to our satisfaction
of the following documents and such other documents, corporate records, certificates and other statements of government officials and
corporate officers of the Company as we deemed necessary for the purposes of the opinions set forth in this opinion letter:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Registration Statement;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Prospectus;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Underwriting Agreement;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            copy of the Certificate of Incorporation of the Company, certified by the Secretary of State
                                            of the State of Delaware on July 31, 2025 (the &ldquo;<U>Certificate of Incorporation</U>&rdquo;);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            copy of the Fourth Amended and Restated Bylaws of the Company as in effect on May 29, 2025,
                                            certified by the Secretary of the Company;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">August 1, 2025</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            copy of the resolutions adopted by the Company&rsquo;s board of directors (the &ldquo;<U>Board</U>&rdquo;)
                                            on May 29, 2025 and on <FONT STYLE="background-color: white">July 30, 2025; </FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">a
                                            certificate dated the date hereof of the Secretary of the Company, certifying as to the name,
                                            title and incumbency of officers of the Company signing the Underwriting Agreement or other
                                            documents in connection therewith; a</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">nd</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            copy of a certificate, dated the date hereof, of the Delaware Secretary of State, certifying
                                            the existence and good standing of the Company under the laws of the State of Delaware.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have relied, to the extent we deem such reliance proper, upon such certificates or comparable documents of officers and representatives
of the Company and of public officials and upon statements and information furnished by officers and representatives of the Company with
respect to the accuracy of material factual matters contained therein which were not independently established by us. In rendering the
opinions expressed below, we have assumed, without independent investigation or verification of any kind, the genuineness of all signatures
on documents we have reviewed, the legal capacity and competency of all natural persons signing all such documents, the authenticity
and completeness of all documents submitted to us as originals, the conformity to authentic, complete original documents of all documents
submitted to us as copies, the truthfulness, completeness and correctness of all factual representations and statements contained in
all documents we have reviewed, the accuracy and completeness of all public records examined by us, and the accuracy of all statements
in certificates of officers of the Company that we reviewed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in rendering the opinions expressed below, we have assumed that the Shares will be executed and countersigned by the transfer
agent or registrar therefor as contemplated in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing assumptions and the assumptions set forth below, and subject to the qualifications and limitations stated herein,
having considered such questions of law as we have deemed necessary as a basis for the opinions expressed below, we are of the opinion
that the Shares, when sold and issued in accordance with the Underwriting Agreement and as described in the Registration Statement and
the Prospectus, will be validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion expressed above is limited to questions arising under the Delaware General Corporation Law. We do not express any opinion as
to the laws of any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled
to rely upon it pursuant to the applicable provisions of the Securities Act. This opinion letter is provided solely in connection with
the distribution of the Shares pursuant to the Registration Statement and is not to be relied upon for any other purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion expressed above is as of the date hereof only, and we express no opinion as to, and assume no responsibility for, the effect
of any fact or circumstance occurring, or of which we learn, subsequent to the date of this opinion letter, including, without limitation,
legislative and other changes in the law or changes in circumstances affecting any party. We assume no responsibility to update this
opinion letter for, or to advise you of, any such facts or circumstances of which we become aware, regardless of whether or not they
affect the opinions expressed in this opinion letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Company&rsquo;s Current Report on Form 8-K dated August 1,
2025 and to the reference to our firm as counsel for the Company under the caption &ldquo;Legal Matters&rdquo; in the Registration Statement
and the Prospectus. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required
under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
truly yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
White &amp; Case LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KPD/JYC/BW</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dyadic
International, Inc. Announces Proposed Public Offering of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JUPITER,
Fla., July 30, 2025 &mdash; Dyadic International, Inc. (&ldquo;Dyadic&rdquo; or the &ldquo;Company&rdquo;) (Nasdaq: DYAI), a global biotechnology
company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food
and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression platforms, today announced that it
has commenced an underwritten public offering of shares of common stock. The offering is subject to market and other conditions, and
there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Craig-Hallum
Capital Group LLC is acting as the sole managing underwriter for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dyadic
intends to use the net proceeds from the proposed offering for working capital and general corporate purposes, such as product development,
sales and marketing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities described above are being offered by the Company pursuant to an effective shelf registration statement on Form S-3 (File
No. 333-273829) initially filed with the&nbsp;Securities and Exchange Commission&nbsp;(&ldquo;SEC&rdquo;) on&nbsp;August 9,
2023&nbsp;and declared effective by the&nbsp;SEC&nbsp;on&nbsp;August 25, 2023. A preliminary prospectus supplement and the
accompanying prospectus relating to and describing the offering will be filed with the SEC. Electronic copies of the preliminary
prospectus supplement and the accompanying prospectus may be obtained by visiting the SEC&rsquo;s website at
<U>www.sec.gov</U> or by contacting Craig-Hallum Capital Group LLC, Attention: Equity Capital Markets, 323 N. Washington
Ave., Suite 300,&nbsp;Minneapolis, MN 55401, by telephone at (612) 334-6300 or by email at <U>prospectus@chlm.com</U>. The final
terms of the offering will be disclosed in a final prospectus supplement to be filed with the&nbsp;SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of
securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Dyadic Applied BioSolutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dyadic
Applied BioSolutions is a global biotechnology company that uses its proprietary microbial platforms to produce recombinant proteins
that are sold or licensed to partners across the life sciences, food and nutrition, and bio-industrial markets. These high-quality proteins
are designed to enable customers to develop more efficient, scalable, and sustainable products. Dyadic&rsquo;s C1 and Dapibus&trade;
expression systems support flexible, cost-effective manufacturing, and are the foundation of a growing portfolio of commercial and partnered
programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary
Note Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the U.S. Private Securities Litigation Reform
Act of 1995, that relate to our current expectations and views of future events. All statements other than statements of historical facts
contained in this press release, including statements regarding the completion and use of proceeds from the proposed offering, are forward-looking
statements. These statements represent our opinions, expectations, beliefs, intentions, estimates or strategies regarding the future,
which may not be realized. In some cases, you can identify forward-looking statements by terms such as &ldquo;believe,&rdquo; &ldquo;may,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;should,&rdquo; &ldquo;plan,&rdquo;
&ldquo;expect,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential,&rdquo; &ldquo;could,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;ongoing,&rdquo;
&ldquo;future&rdquo; or the negative of these terms or other similar expressions that are intended to identify forward-looking statements,
although not all forward-looking statements contain these identifying words. Forward-looking statements are based largely on our current
expectations and projections about future events and financial trends that we believe may affect our financial condition, results of
operations, business strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking
statements involve known and unknown risks, uncertainties, contingencies, changes in circumstances that are difficult to predict and
other important factors that may cause our actual results, performance or achievements to be materially and/or significantly different
from any future results, performance or achievements expressed or implied by the forward-looking statement. These risks, uncertainties,
contingencies, and changes in circumstances relate to, among other things, to fluctuations in our share price, changes in market conditions
and satisfaction of customary closing conditions related to the proposed public offering. Our actual results, performance, or achievements,
including our ability to conduct and complete a public offering of our common stock on terms acceptable to us or at all, could differ
materially from those expressed or implied by the forward-looking statements as a result of a number of factors. Such factors include
the uncertainties, contingencies, and changes in circumstances discussed under the heading &ldquo;Risk Factors&rdquo; in our annual report
on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 26, 2025, and our other filings with the SEC as such factors
may be updated from time to time. Any forward-looking statements contained in this press release speak only as of the date hereof and
accordingly undue reliance should not be placed on such statements. Dyadic disclaims any obligation or undertaking to update or revise
any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other
than to the extent required by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dyadic
Applied BioSolutions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ping
W. Rawson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
(561) 743-8333</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:<U>&#8239;ir@dyadic.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>ex99-2.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dyadic
International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JUPITER,
Fla., July 31, 2025 &mdash; Dyadic International, Inc. (&ldquo;Dyadic&rdquo; or the &ldquo;Company&rdquo;) (Nasdaq: DYAI), a global biotechnology
company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food
and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression platforms, today announced the pricing
of its previously announced underwritten public offering of 6,052,000 shares of common stock at a public offering price of $0.95 per
share. The Company expects the gross proceeds from this offering to be approximately $5.75 million, before deducting the underwriting
discount and other offering expenses. Closing of the offering is expected to occur on August 1, 2025, subject to customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Craig-Hallum
Capital Group LLC is acting as the sole managing underwriter for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dyadic
intends to use the net proceeds from the offering for working capital and general corporate purposes, such as product development, sales
and marketing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities described above are being offered by the Company pursuant to an effective shelf registration statement on Form S-3 (File No.
333-273829) initially filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) on August 9, 2023 and declared effective
by the SEC on August 25, 2023. A preliminary prospectus supplement and the accompanying prospectus relating to and describing the offering
was filed with the SEC. Electronic copies of the preliminary prospectus supplement and the accompanying prospectus may be obtained by
visiting the SEC&rsquo;s website at <U>www.sec.gov</U> or by contacting Craig-Hallum Capital Group LLC, Attention: Equity Capital Markets,
323 N. Washington Ave., Suite 300, Minneapolis, MN 55401, by telephone at (612) 334-6300 or by email at <U>prospectus@chlm.com.</U> The
final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of
securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Dyadic Applied BioSolutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dyadic
Applied BioSolutions is a global biotechnology company that uses its proprietary microbial platforms to produce recombinant proteins
that are sold or licensed to partners across the life sciences, food and nutrition, and bio-industrial markets. These high-quality proteins
are designed to enable customers to develop more efficient, scalable, and sustainable products. Dyadic&rsquo;s C1 and Dapibus&trade;
expression systems support flexible, cost-effective manufacturing, and are the foundation of a growing portfolio of commercial and partnered
programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary
Note Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the U.S. Private Securities Litigation Reform
Act of 1995, that relate to our current expectations and views of future events. All statements other than statements of historical facts
contained in this press release, including statements regarding the timing, size, terms, completion and use of proceeds from the offering,
are forward-looking statements. These statements represent our opinions, expectations, beliefs, intentions, estimates or strategies regarding
the future, which may not be realized. In some cases, you can identify forward-looking statements by terms such as &ldquo;believe,&rdquo;
&ldquo;may,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;should,&rdquo;
&ldquo;plan,&rdquo; &ldquo;expect,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential,&rdquo; &ldquo;could,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo;
&ldquo;ongoing,&rdquo; &ldquo;future&rdquo; or the negative of these terms or other similar expressions that are intended to identify
forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are
based largely on our current expectations and projections about future events and financial trends that we believe may affect our financial
condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs.
These forward-looking statements involve known and unknown risks, uncertainties, contingencies, changes in circumstances that are difficult
to predict and other important factors that may cause our actual results, performance or achievements to be materially and/or significantly
different from any future results, performance or achievements expressed or implied by the forward-looking statement. These risks, uncertainties,
contingencies, and changes in circumstances relate to, among other things, to fluctuations in our share price, changes in market conditions
and satisfaction of customary closing conditions related to the public offering. Our actual results, performance, or achievements, including
our ability to conduct and complete a public offering of our common stock on terms acceptable to us or at all, could differ materially
from those expressed or implied by the forward-looking statements as a result of a number of factors. Such factors include the uncertainties,
contingencies, and changes in circumstances discussed under the heading &ldquo;Risk Factors&rdquo; in our annual report on Form 10-K
for the year ended December 31, 2024, filed with the SEC on March 26, 2025, and our other filings with the SEC as such factors may be
updated from time to time. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly
undue reliance should not be placed on such statements. Dyadic disclaims any obligation or undertaking to update or revise any forward-looking
statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent
required by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dyadic
Applied BioSolutions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ping
W. Rawson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
(561) 743-8333</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>ir@dyadic.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>form8-k_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form8-k_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ 'X# 2(  A$! Q$!_\0
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M[)MZ^_T]Z\^>*Q'+&V_H8NI.R/2K2ZBO;6.XA),<@R"1BIJHZ-:RV6D6]O,
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0^M6**%"*=T@L@HHHJQG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !F *H# 2(  A$! Q$!_\0
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M9-OUU"BBBI- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
' **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !E *,# 2(  A$! Q$!_\0
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M.X#D#G\ZBCU#0HQ;01K&JOM>," A4+90;CC"$_,HS@GD>U-@U70H+%?L\>R
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@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>dyai-20250730.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaKCibP9z5Z8mekhvWB7bfl6Ly4mHLBs5SKvqoX2cREP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:DYAI="http://dyadic.com/20250730" elementFormDefault="qualified" targetNamespace="http://dyadic.com/20250730">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://dyadic.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="dyai-20250730_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="dyai-20250730_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>dyai-20250730_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>dyai-20250730_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="dyai-20250730.xsd#Cover" roleURI="http://dyadic.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://dyadic.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 30,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Dyadic
International, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001213809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-0486747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1044
North U.S. Highway One<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Jupiter<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">743-8333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DYAI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dyadic.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>dyai-20250730.xsd</File>
    <File>dyai-20250730_lab.xml</File>
    <File>dyai-20250730_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form8-k_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "DYAI",
   "nsuri": "http://dyadic.com/20250730",
   "dts": {
    "schema": {
     "local": [
      "dyai-20250730.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "dyai-20250730_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dyai-20250730_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://dyadic.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-07-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://dyadic.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001641172-25-021911-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-021911-xbrl.zip
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MRYO7+,8G=K52<>SGN\$HQAD)L+4@F+[L@CO-9M..O1FT@%R,.<FD:[9VCZ%
MN;+RXA(\ID)"ZF[@/9D3UL%U.W%N0/%.:".!X@SJH2V<0*XU83-;.12^6L^
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MC<VD#DM3$Q0C%F,@&J46E6)/1/QC*\[8"4_WO5 82M=< %9U-#194'38O8&
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M=YZ(V\5>\+ :MD+24H:'BLU>'S!E#!)!/DZL*USE#0WKJV1:N;M7@"VV#J\
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MHU^JLEVC[(VCK(BRIH[FR3J99\U-E-11JRH,J)+VT[_YW_O/)T64G(.6<YZ
MR /UU.FLK(76U,)T(DVP&JMOX_-S5F?KV]39:,]/@--_?3>@)>RIS,YA]!Y^
MJ#LZ,PAK? DG:@9];9NZ@:D"/2U*ECC6\^P*?TB7RW3>X%/88IWDJ;8N2CCV
MIDJ7:57! L)C%VF5PC3"S)G)HD\=2@=W9_3^G-'WN!UEG]#2S6Y@$Q;+K%K5
M=!02U=FCZPPN=5Q3L_/QV3D<;MPI^*=U6\TOP/CG4]?;+#%NBV69Y^5UO1/5
M]V@;'!_""'[[^6UZGM6-R-EW#0@QMM9^^YEEB-LHL(SK*@7Y!&<>EWJ9Y? O
MMT/>I?,6C3X4#_#7YQ]@4Q3G]/X*I/* %)=?JPB;3DCL=AL[ 4D$&^KXAX</
M:2LET+U%NHCI*_ALU>;R39#!;4X#J8TXU*\WN-7Y$WMSV(\@XK*K-+^) Z'E
M/@RFZ[PQ4AY;]Q-5ZT1%\,.+LEI%[PX>1GLO8$ZBU^5A]/#APX,'WSW\_L$/
M^WC#S/.6Q2Q>5O4:/MW"RE0I]A:/46D.S"%HS_.+X'/3B?N>G8,H:>B]!A8:
M#B[(]#G\1<0WC,U^&9_+"O3748OPIR7,&0Q^@4=]@:>X;I."I/Y;F-'HT<.C
MDQC_]VE45OC?TPT+Q!<*[(U&)WYDMFR/X4F4-JZ[H&'7[I+3/H#JX#KM5F,Z
MR>K;+Z#AG2V-/*$=@W=]#4WP^[P30,2MM(DS6*)LE15)=1.=N963)J:359K
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M.(V%7"84G7%P<AFD6K8]^)QS-'%(3#5ZG!@Z;KSV\F,(Q6F+*DWJLH#MS/;
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M#V@\C DCP!C#1X(U4RP$$DX=1]*&L'#]/$2:@]846CGC+^BA/?%?>H/Z (6
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M7N/(]=?U8(-IP'B34E2ZGD]^!'<D8A6>7#:(P5P1^_4BQ81Z@=4DPIYQ!4W
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MP4A(+%]QD-MT2PL4W8L]UX?PE<"#\-(YJ_76A0P=SEOU'GO@ ?;\HH4=$UW
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M9HWV\8'E4RY ,0954]8*+/7"_0.43"*_CT43<SY9#B#5S)M2F,&5!EL?=]*
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M==:E4F&I#QM@1X?['CU&<OM2[#! UO,AD1'\QAYF(?!SVM%F>"?WYR[P^SC
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MY'YN1.352@]A^OM'6V7U(M/<H6U$OH.Y]GE!H".^:6HG#AHAY':&SL>"YE(
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MYM!!4\?9]6'A->0MO(3C>96 ED(%+82O4>"8+%Y\2D/L6!@P[!IA\@*&M/#
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M)[BRYUB6AY-U](_]J[ L4JO\P56><?+;O*5BD2.O7E^4*&Z<NE<RH6#WO/H
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M>3O7N/%;PC-2DBW5[J!I40(U-FZ' '4[<^N>#TD*7+QR.%'"J+U2!\! JN?
MX2,'J OH<[Q$7+LX#';\.5&?+;W*TXWX.LUJ.O&Y6JPD4B)0>)X9MQ#!I9$0
M\,/?^W(P_)VS@G-=+NB\^H>HQ\XW@72,6F+"2:&Q&ZI[C1MP;]AOEG'C&MVP
MIHOWI5?GV'>X;2[IMCT;RM@7_TS<K1/L<<2@W_G[0>#+.,T].#%*@>;67-0-
M.NUHFBHZ]P2#C*X\G(Z>&US@(8YD -;36B.+H"A/ND^W8*'U\WABNKM\E@;I
MAEYM9Z"K+#'>IA_FIM2M_'YV(W[)SWJI]UB*-JC*V"U454RGQ&C2G>0"C_83
M& 7W !QR@-II0+"##59(R$YNRFUQUP.7)'F:!49VWF:(#D5_8)6TBS;']^&Y
M3CAWSR/_IY-QZ/_QWM(9HT,Y /O^9%BD2B"T'*!)>HA!MNN$!8GO+4>Y-_5Y
M=T'>\R%)C93797'P'(M+UF3-O46!V2D_R[_I.4$&X7^#GA%%]8$\4NE4$: L
M2O7+!L $OT?7 \AE1MX[L)_K"<L;1(/8\QMU'"V#41*0 V#\"A2$[L";W4Z]
MYT/Z_A 5HN>VW#H9E8ZBAUA38+,.TO; C6-JM1LJW(5@)1#%*P$]5A\DGR+5
M$HUB+SAV0.'UT="G0FPXWV2WF^[YD'Z@W?2>M.W$<>Y,)YWM(UBS1I[S[!')
MK"YS]&FB8@,K;FJ\!5B;&</&Y\[YZ3$M2PFB]_:8XUB]&2?&W$2:9F&&%9$)
M1.=P7BI"#'99VNNV7E.*$39I\-@D>B6GQU@;/$2<Y_\IJTLAC'6)@_ @<_>%
M $3IA*ACGDU6V<SAM?,VP6*;:=^-))"<P1XSV"XUGQ?\'3IQ#J"5 U(ZB=:M
MNDR;$(J8Z+0@O@'3'+)V12%AT$[3BF@Y9TEQ2?%>%!M"[MR=P44*.KHH^\+G
M3A/AYXA<(9X?>@!%6*5V85Q%:AI*VU!$B@C*ZGF2^Y36BQ+.BIA%FHG(,Q&4
M]>.Q^T>@B95$FN<5&!!(6IR1+2,*)JJN;8/FH&QHW D\#BK9FC ZC_30#46D
M8W0C.P<0LZAR66_\]W"%:5[#.Q:8[AZ8SU5AVD%UMBXPS6DXH>MP=Q?<HSCF
MW6+RW^]B\I\>D_]^%Y/_2_;RE]/QKU"?/#XBA?(LN7&HS.?B&$3-$DQLLJ6_
MJC$CP:^LY%<V,B2+G$Y^EV@9<MJ5[#D$5;:H$RE!LEE5(#0A>M7;U2J1ZD6=
M)^ ';UF$5,?7&6=:L0^88NA2[AU][(R!EO1\GUB/,&2DF:P)*>O+>5E4LOF(
M!,YJCU1&%<T7H1YDQ."PO<'8AQJ73UX\F0OJ'@;2H]P8C-&O*TX#D"QEQ*6C
MDH<>Q9+"SFH>8>J"]_]N+CG]:80/=]/T@BP?&';ZX2*;95@4Q-%3U()D58(*
MH8YKRGT7>EJ87'S^:[ED>TH"U%R142=(0I4X0QP8Z.NK3_,6%N@2@PO557J#
M,196B'W5MTY^$I(:9[G$@J0/^V&>HWEY;)]X17W=5F"9U*FH[($C)=A 8J')
M]&W>+_]L02HX=%:X#Y=H%;A( <TY?EA03F21&3LT3Z[IRU?\X<&,R&X/<F&P
M#\T-9_Y>R9&DK0I;-F6J&22?%NJ;(:92H1G1 $257F4@M$"VO'CY^NV)JR)/
MMHMR8O3*>>'7>YL%CQ;UI":3W?)BLR_"X8+H=?L^16R@Y7.6()1B@7)P2;%1
MVF5,%D#'L.+W30.#0L@A((*2-4PSP+%W%T2HU= ?H9KD5>5R<R-;A4W@7M"(
M\$*Z[X=(A3QO3UV7\RQIK!UJQ!*TZKEA:E#X90.1$SR;PQ3C!G@BR0\?]HU4
MI!EB:6(YB=Q&H2^E%:$6A J%\I]FN; QU :J+[D!XE?W?G$44+3<G&H_[L*?
M3E"3Z>;OQ1&,*[U"DYZM?\GO3TP\H-,0W*0T6OWQN\@FAH=!/DDJICFAT<'1
MI=S<[M[ID2%T.M:_0L/\G8"QB+T<!^7R8 TG(FW\]'MA* >WNW^IV(NF^VV1
M!WTK7DGV5,_39Z7H=!(H'#B=LQMV>!E DH0^36U3B;"@"^4_OGL<'QT=[3P2
M]WQ(2&/W<HD,0=Y'.*XY!A"3,!3W0]S-M7+H//$&2F0;$TX(']6D3H-C&<FY
MLKXHTE#YHRKR7$9VDZ-K-"L8\*4J0.>6MIWP0%55(P-=A@,M?5+VNYSQ@?O(
MJ#ZJ1&\\\(@ 'D1Z?/H1C[8_X4)>,GK$HQ>"U$NNRFRA-\>B;&<-<8F%^=D]
MX>G;1<EL,Y!%/ZP;N=1(_^RSZ4G P,X'XY%2PD'2G1[>8R.;9">L[OF0CH_9
M]<$9U=/)<P,J><K0YFC+.&U62-(;+O_,OXOG!!EL,@8_N=!L&'35XQ24'B7
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M"[!,2W]WR]Z<JS+K=>+N*EJ.<L0;-\,E;TI0G8U<OU% "_SV*$WR:8"GE*3
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MZ\YFN7Q/^\@XWD=X,QSP R?*Q"::<UJ#D,@5,86734RAB2D\Y1LDD=Y[GCG
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MI-DXFJE/"N5@-%A"]W+,$R?T(':;EB#,_#0:RM",F*08W=Z4EDH (RAVF2]
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M&M#&''@SA2\D3A30%[(4BU2Q@E =2U2P,$=C)MOD/+;=@-:7Y^V"*_JBJ)3
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M,;TYT:3+J77W]#V-1D'>@QR<P_?4NL(Z66)NY6@NV/%5.B(KB0Y<9&JB<EO
ML96(1%[FV 31",[HJX%\.?81*: 0E584^S S4SYUND_AIV\G\-@(!7T5PLV
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MV!8-NZ873@&<4S/U_]ILTEQN6K%4@P1(&SZN(<(M!\X:2TPUT>"O7$TTM6=
MTD4 -G81^*C$>V1T!',Y_6M6M#9J%R>A_;R_T?O8\/+!8_V C=W4-0/0G[KB
M1DZ]-1N[CQ/@$P#Z\P9QOR68J]S&;NB:[G;LMUO/7K[:>2Z^>='K?-OK]39V
M.V=T&67_\-W1T[]_N]O;.]#NGQF?I_HJRL;N;*U7>[Q=LGL@WA;L-_;%I?3E
MU^[)X]V3C>IO;'B46\_^%OU56O@S-?IKMO\ 4$L#!!0    ( -R# 5M((XAU
M/PT   \W   *    97@Y.2TR+FAT;>U;:V\;MQ+]+D#_@0UZ@P18R0_%2?VH
M43];]SJ.83NWZ$=JEY(8K\@-N2M%_?7WS)"KEV6WM[=MH" %4DF[?,R+,V=F
MZ(.?[MY>'C8;!S^='9WB4]!_!W<7=Y=GAP<;X1-O-^+K@^-WI[^*V[M?+\^^
M?]:SIMP36YM%*>[T4'EQI<;BQ@ZE2<*#1-PJIWO/,!%3K__7>?MB*%U?FSU!
M0Z?_]D6I/I4MF>L^7J7*E,H].SPX?W=U-[]#JR>'.I_L_=X>/-;KWU0@"2L=
M'SXW75_L'VP<0P:T+CZN_TXFG.X/RK^8A[-/ ]W59;.QN]O>_N=8^2+T\;<P
M<3J1F4Z;C0M:V\A26R/S1%R8M"V.C+&52;'DM=.I-GUA>^*ZZN8Z%>]Z/2P:
M'KU.-G>VD\W-37$[D [#\>S$#H?6B-O2IO=K+J)_6L\?*E_JWN2OY.+G]]<7
M=V<W2;-QGLMV(GZN\HGH;"5B>W-[1SP?9M(/]D6P!;'*%%X\S[./E=T/0YX[
M_B&L$^5 B?@.*B^DF<27+\6+*^DS^7%/G/YZ=/$R$5+T<]N5N>AJ6ZIT8&QN
M^Y-F(PWS0'5:>94)F VMZE.9RVZN1.%L5J5$#AG6 %ZI-9)YI1*\4:GV]$(9
M2%4IA^D]F&R@76A35"7-+Y4V'ALX@1WP6.2Z1SMH1>:=X(W-F@UI,F&JTFF:
M#GKQ4YL,VG!ZF6HABP+'@(7D157J7/]&IT&7GO8KG%:E=!/15T8)]0F$>J:S
MR&4),H;8L[29Q#KQC&7,<Q'.6;,!1L-2:J1MY?/Y@97)E!N#RE)AP7 <[<KC
MZ*?',0W'T=-Q%+*$+I8GTM:*AGZ[V=[=$85RS0;/;XL[4!:52[RH%)01M7UG
M/;.;*I5!O,X.\5S[V:*E%5U%LG+VDQ[*4H&1;W?:;W8$[#AG*7<5Y*%$IEC'
M- <K3UED863:I^"]9(U8O'>S'8@>XY5OBY/<^B@!6F(Z O0$HDG&5M@TK1S9
MV%'5AVI%/ 2)\%7W T;1&-AAB7,%_:5QT=2:C,W"M]?6"=1^;$W)/W%2]UL_
MR3ROALW&B2QTB5/YH[-5(2XO3TC/,EB0#.;I+9P'5I9]>C@U*5A/+SJNVD:^
MZO0SD5^C#XV08^!"</;(09-NC"H?N):Y4TTJ'%MWSX<SV@*Y!W*X#M]3ZPKK
MX''@Z/#-$Q6^2@=D'#&@P.>,5&Z+(4 #7LI<^1 #((M[57ZUB\]'/B(.HH^"
MIX;3Q<Q,^=3I+CRX[-H1(@HB1E<%;]_CJ-^=L'W480I*]Y4T[,TEX %&P3=@
MIA^HO"><ZFN$=0[?"(HP$S("B@KG",[BMM41+\XUW,>5;3<;G4ZGM?VF\]WV
M[DL  E $'P2X@O>9&.MRP#O?SJ@E&SK[E ZDZ3-%0QV"?PVB;L].IB!I%HAV
M.1!U>':FTEP26U/"FXW((2;/3:+ 1;, U@DLY'JH#<4MF+BGF%=Y6#V@2N"/
MEJ8U9!HQ5PC\TZ%80)8Q;@<R6.QU5*X/7[,QQBE:YO_LI"W.<BSDK &P2&VA
M _8(P.;_I6T(L 0L8;NE!-(CA3<;(X"_*69@J7J2JA=CU<4;14CGX/WA>#QN
MPYC:?3LZV'A_2+ 5PD1(+V/ F \MXD%D2<0102VRE3UQ]K'2Y60ZZ"V["@]@
MW8'JKMKB%R!I+%F2BD8*4/NV(D(ZFYN)>*N-4;*PN8;IO[T2.SNO-@$_2+$J
M5\7 &J;XQ>NM[9>BTWG5>HUID5HUE#J/_,RD\D,ZR(=M"*S-C/&QZ6F"O@AS
M0_\ "XV!NDB*A*B ;!0!7&#!,&6U7@*$6Z'LM74N:^\;->(49Q1T8)5$P,PL
MEC"V)*/&AF5%MF^"WDF#7D'O$?0 %B')*&6=4,V/ZU;L9+#BS/DF6-A1*H$E
M"'LKAO3PL10Q.5-9GL%&10/(L=*V'_#"(]#SEG@Y'FA$8@['O'6R1)3CM1'?
MJSRCW2J3RW&O(A/5E@E=<. 6J<K'"A+OQ8PL@+W [8PJK.$#PY.P]TKZJ.PQ
M"63Y1;H\#0TOHJP2>E*+@M9>"%KU81O*C'-.\FPND\CA9@=I@0^GX%P<'[OI
MT9T+*T> +'BZM=OI) 1C) 8B;?IZ$#\3^0?'AT==6Y7-1BR<'%%- &[R6-M;
MFU=L,VM=-OHRBE]UDK%*/9PUKJQ+B;HL50X0=9&5^ ?%G:%.G>U2;6A:UB''
M$-(+.MM8 N")8&A=@VHV>#G"KW M&?D/.!BJ8'!QHI"N-.1?9,JU%?( *TI5
M8D6E"L2WYJI5(8?Q7+R!<^:J&?O(<C)'C.3*BX?DP_[*<,4MU#^BGXM9DAA2
MF09X5!,IE##%^ES8WF,*@-E\P0Z;U^7"",M.MGCL*<!3M_+/X?<RM=]LS-7'
M_,0#BP< 8ETI>KGZI'F3U/JR-</Q4'S5 WRK"-<$$H@9$EC/POW/PAN5J<8,
M)K%@#_[<U@4QY5(=T\8H>)519+5])X=?6J$'#'S3:HESK?)L3US+OMK' A\K
M,BM,%*U6;+0=G%[\IR8CT-_JVA+VL"=>%^6^Z"*(*3=]=IS+]%YL@3&*E1GX
MN#LZOCP3)V>7E]='IZ<75S]^_VSS&?^^O3XZJ7_''>)JJ<US67A04G_;1Y#,
MR@'QM/FO5;[I[J9>8Z1<B<B?UR(M;;$HXUSU>,9I/6-NZ9FX[DZIN7A#_R,.
M\ E)K!!*UREYWPIURSU8#DDR"@H[LY2PV?6B#-D&9GM=+ZX^IYD-4DW0QE]H
M<U_#]GQ0.Y'L_>'#FXTK^$)QH_K29>0DD/^/\;5U:2W7EF[KXL#72/[YN5B5
M^FB3YA5B&%4$67-YU-RTK.,9;NO051HJ:6*7X%:%A&3[S=$?1]M)/:W9V-XZ
M6S%O6OB9+?!J<8&ZTN$E OM .KA "IDC[F1-@?_[]FV;^JXCRE'FUK_$1S]$
MMQMR04, FWJGW9TDP!4NY"AN=U0.X=PY2N5#&R3F,D3%2*N0$O4J!%)$]Q&)
M"QD0$I<Y\866"Q8V"T^I%P><X,CU"HK%GGIY)M9G6-Z:6U@S;25174OZ<=/C
M1YR75"A"3"?-)Z&0D3 :RQ6S3913E1@$/%X@3@*X>=PH:F2T0 81RX5 :A$5
MVI"DD@6Y4<,**++GB958%:(AL'7J;W&.R D=$CLUQQD!/Q7EG,0$F$I:E+1W
M"2OBU/R&9$Y<0,C 7B*57+.>V I?D35GM%=O\I29<R'),7H*A>Y8;V2*1RJ)
M1<=F(S['_O6S>FC-Q_)STJLVU8/GP+; @\6*&:&DO_S4#RBG?T )\+-Y0 I+
M??DI-$2)^H/'EG4A\X>$S^U7/Z3,_,&SE819T[=D34N#@QZ7VN!&T;D<*3$M
MB<0BG(LGR,.P<^GF^L%>3-.!(*\ PVME-QN/:QM^)"\AS?Z ;8BJ,T^81CR7
MD:YZ?2X) H#A,)P_/A?4-1M=22D*J.]3#Y>@]5..!>?R0W"3GBKV5;GH87@,
M%1T- _#2A>8/B6*L1#17/AZ2 3]O-AW/7B:+J0\$6>7!&]E"N>DAK3R\$!Q/
M/(L3N),!\'^+5,+;YU!M^#4=.UL@=)JY'PR%+M-KR.6TFXW@0)Z0NC8CFX.3
M>V/'T6^9\-UI?P\RJ:'O2#&AT!9.61^0//SD0,+EM%2[M!IB:;Z.,S6:3%,^
M!@' O5#BR6=CKDVNAY3T4 )*_MFZ.)4DFTKVH1 L95'@*DHRH=8_Q14N5%%]
M*QV0.@)'H1I,'L*%+@CVVB"7AY#/Y3=3YA/JV'-;AO8EQ\RW.X(!_*%=X@%1
MG!^#!T[;8__C47'7#GVE:$-DFI,MR>A1^4[#)\8-+:&%& &Q -_<0%Y:D=1B
M#2&<!KXM$>Y1+.@NI.)S5PA"E]%CMB>UQ$3UJ4L'D2)V#MQ.6;R\T1;OGM9C
MLBSBN4#<;+ 1=#77!NCV [:MHAG%L*M67!BA$T<^8/YF"5W=89\GTU05)5<#
MN*?+^[.7(BNGLFXPD3E3@K,+0=QZ]><LP#/,B@((N;^IAEV^+E(?@+:XI>!8
M'X>('N.EDS]O,=10J9C>6>EYH"1CFA@S;F"7XCSL6T>.:#G2F* YKGG47<BM
MS=:_.0+P:A-%D8,CQ*E*%;,5;W !7S[LS] R;Z4#K]NOZRLN[!BJ.AQA#MGS
MXBP9T4,MH-!V:S:J(F,###H"3&=3Q&>HE_]^Z'D,$@I?()T&M>1,INB7-A/4
M;.!Z?19KYUB9[ 0BKLB3Y)J]1\ 4-9("E$C#);)9C3\"OEBFY>:7U&2E5.F'
M5?>G?0?67BGO8Q,T<$TOZ"*6#WV/)5Z;C3_.+"$_Q<)?LE2#'$@;/JXAKBW&
MRQI"C#6M,8?'HS] VH5QS4;L(/!1B3?4Z CF<OR%5;/6AWPJ-X1.\]Y:Y]YK
MKH:GF@!KR]0UNY]?VN)&CKTU:\O'"8!)K]DXGR+L=P1KE5M;AJ[I+L=>L_%B
MY_762_'F5:?U7:?365MVSNCR"=@Y>'^HW0\9'R6Z=4*73M:6J35W:,N$/]'<
MV=X7[PKV='OB4OKR:Z_GZ5[/W]Z-><PX:EUNT!^TA;]PHS^$^R]02P,$%
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M\-$S0.2O.P-J,NLZ?RW4F0O#$I\] TP#,3GW0!7F$%H$NZLK$V+9$Y5]3/:
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MYK%?VJ45H%P?,/DV80\8H89AZF#;L:>PJX])EZGZ"+<)'^+ND7+ZB/2XBNJ
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MAOS$O%Q,LV4L<D^N4"YS\XK%8F:[M)8,N'JEUDLL5E/87.;J/!+5>7RN/60
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M.(N8R!3I26:[[B]\=N< PN&K=_'.&I.!H]U%O>%]@Z;/5SU'5069,%EB\63
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ML\J:H A-&P;,'=_%*2R'FI1?_TG[2_;?P2+_+]D_8?]R#0'<8-#QYX'Y@7/
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M_P902P$"% ,4    " #<@P%;J!M>UR8#  #<"P  $0              @ $
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M,2YH=&U02P$"% ,4    " #<@P%;2".(=3\-   /-P  "@
M@ %_R   97@Y.2TR+FAT;5!+ 0(4 Q0    ( -R# 5NI AJ@#A<  /JS   +
M              "  >;5  !F;W)M."UK+FAT;5!+ 0(4 Q0    ( -R# 5NL
M.=Y4A D  !4*   /              "  1WM  !F;W)M."UK7S P,2YJ<&=0
52P4&      D "0 9 @  SO8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dyai-20250730.xsd" xlink:type="simple"/>
    <context id="AsOf2025-07-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001213809</identifier>
        </entity>
        <period>
            <startDate>2025-07-30</startDate>
            <endDate>2025-07-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-07-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-07-30" id="Fact000004">0001213809</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-07-30" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-07-30" id="Fact000010">2025-07-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-07-30" id="Fact000011">Dyadic International, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-07-30" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-07-30" id="Fact000013">001-32513</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-07-30" id="Fact000014">45-0486747</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-07-30" id="Fact000015">1044 North U.S. Highway One</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-07-30" id="Fact000016">Suite 201</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-07-30" id="Fact000017">Jupiter</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-07-30" id="Fact000018">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-07-30" id="Fact000019">33477</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-07-30" id="Fact000020">(561)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-07-30" id="Fact000021">743-8333</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-07-30" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-07-30" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-07-30" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-07-30" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-07-30" id="Fact000026">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-07-30" id="Fact000027">DYAI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-07-30" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-07-30" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
